2022


  1. Schomerus G, Schindler S, Baumann E, Angermeyer MC (2022). Changes in continuum beliefs for depression and schizophrenia in the general population 2011-2020: a widening gap. Soc Psychiatry Psychiatr Epidemiol, 0, 0-0.
     
  2. Sander C, Rieckhof S, Peter LJ, Horsfield P, Speerforck S, Angermeyer MC, Schomerus G (2022). [Psychometric Evaluation of a Long and Short German Version of the Prejudice Towards People with Mental Illness Scale (PPMI-D)]. Psychiatr Prax, 49, 144-151.
     
  3. Lüders J, Sander C, Leonhard A, Schäfer I, Speerforck S, Schomerus G (2022). Trauma assessment in outpatient psychotherapy and associations with psychotherapist's gender, own traumatic events, length of work experience, and theoretical orientation. Eur J Psychotraumatol, 13, 2029043.
     
  4. Lüders J, Sander C, Leonhard A, Schäfer I, Speerforck S, Schomerus G (2022). [How Outpatient Psychotherapists Deal with Patients' Traumatic Experiences in Consideration of an Additional Qualification in Trauma Therapy]. Psychiatr Prax, 0, 0-0.
     
  5. Wittekind DA, Kratzsch J, Mergl R, Riedel-Heller S, Witte AV, Villringer A, Kluge M (2022). Serum ghrelin is positively associated with physiological anxiety but negatively associated with pathological anxiety in humans: Data from a large community-based study. Psychoneuroendocrinology, 140, 105728.
     
  6. Widmer M, Schmidt-Recla A, Steinberg H (2022). [Forensic Psychiatry in the GDR: An overview]. Fortschr Neurol Psychiatr, 0, 0-0.
     
  7. Kilian C, O'Donnell A, Potapova N, López-Pelayo H, Schulte B, Miquel L, Paniello Castillo B, Schmidt CS, Gual A, Rehm J, Manthey J (2022). Changes in alcohol use during the COVID-19 pandemic in Europe: A meta-analysis of observational studies. Drug Alcohol Rev, 0, 0-0.
     
  8. Leonhard A, Leonhard C, Sander C, Schomerus G (2022). The effect of alcohol use disorder symptom and recovery narratives on problem-recognition: A randomized online trial. Addict Behav, 134, 107426.
     
  9. Schmidt H, Koschinowski J, Bischof G, Schomerus G, Borgwardt S, Rumpf HJ (2022). [Attitudes of Medical Students Towards Alcohol-Related Disorders: Dependent on Intended Medical Specialization?] Psychiatr Prax, 0, 0-0.
     
  10. Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Verde PE, Correll CU, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl TB, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Leucht S, Cordes J (2022). Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial. Lancet Psychiatry, 9, 291-306.
     
  11. Kumral D, Cesnaite E, Beyer F, Hofmann SM, Hensch T, Sander C, Hegerl U, Haufe S, Villringer A, Witte AV, Nikulin VV (2022). Relationship between regional white matter hyperintensities and alpha oscillations in older adults. Neurobiol Aging, 112, 1-11.
     


  12. 2021


  13. Ulke C, Gfesser T, Fleischer T, Altweck L, Hahm S, Mühlan H, Heller A, Beutel ME, Schmidt S, Grabe HJ, Schomerus G, Brähler E, Speerforck (2021). Later-life depressive symptoms and anxiety attacks in displaced and nondisplaced populations Journal of Affective Disorders Reports, 3, 0-0.
     
  14. Strauß M, Petroff D, Huang J, Ulke C, Paucke M, Bogatsch H, Böhme P, Hoffmann K, Reif A, Kittel-Schneider S, Heuser I, Ahlers E, Gallinat J, Schöttle D, Fallgatter A, Ethofer T, Unterecker S, Hegerl U (2021). The "VIP-ADHD trial": Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients? Eur Neuropsychopharmacol, 43, 116-128.
     
  15. Paucke M, Stibbe T, Huang J, Strauss M (2021). Differentiation of ADHD and Depression Based on Cognitive Performance. J Atten Disord, 25, 920-932.
     
  16. Peter LJ, Schindler S, Sander C, Schmidt S, Muehlan H, McLaren T, Tomczyk S, Speerforck S, Schomerus G (2021). Continuum beliefs and mental illness stigma: a systematic review and meta-analysis of correlation and intervention studies. Psychol Med, 51, 716-726.
     
  17. Dogan-Sander E, Mergl R, Willenberg A, Baber R, Wirkner K, Riedel-Heller SG, Röhr S, Schmidt FM, Schomerus G, Sander C (2021). Inflammation and the Association of Vitamin D and Depressive Symptomatology. Nutrients, 13, 1972.
     
  18. Schomerus G, Baumann E, Sander C, Speerforck S, Angermeyer MC (2021). Some good news for psychiatry: resource allocation preferences of the public during the COVID-19 pandemic. World Psychiatry, 20, 301-302.
     
  19. Kilian C, Manthey J, Carr S, Hanschmidt F, Rehm J, Speerforck S, Schomerus G (2021). Stigmatization of people with alcohol use disorders: An updated systematic review of population studies. Alcohol Clin Exp Res, 45, 899-911.
     
  20. Sander C, Rieckhof S, Peter LJ, Horsfield P, Speerforck S, Angermeyer MC, Schomerus G (2021). [Psychometric Evaluation of a Long and Short German Version of the Prejudice Towards People with Mental Illness Scale (PPMI-D)]. Psychiatr Prax, 0, 0-0.
     
  21. Schomerus G, Schindler S, Rechenberg T, Gfesser T, Grabe HJ, Liebergesell M, Sander C, Ulke C, Speerforck S (2021). Stigma as a barrier to addressing childhood trauma in conversation with trauma survivors: A study in the general population. PLoS One, 16, 0258782.
     
  22. Dogan-Sander E, Strauß M (2021). Case Report: Treatment of a Comorbid Attention Deficit Hyperactivity Disorder and Obsessive-Compulsive Disorder With Psychostimulants. Front Psychiatry, 12, 649833.
     
  23. Schwarz J, Mauche N, Oehler C, Rummel-Kluge C, Hegerl U, Strauß M (2021). ["iFightDepression" in inpatient treatment : Evaluation of a web-based, therapist-guided self-management program on a specialized ward for affective disorders]. Nervenarzt, 0, 0-0.
     
  24. Rieckhof S, Sander C, Speerforck S, Prestin E, Angermeyer MC, Schomerus G (2021). Development and validity of the Value-based Stigma Inventory (VASI): a value-sensitive questionnaire for the assessment of mental health stigma. BMC Psychiatry, 21(1), 570.
     
  25. Jawinski P, Markett S, Sander C, Huang J, Ulke C, Hegerl U, Hensch T (2021). The Big Five Personality Traits and Brain Arousal in the Resting State. Brain Sci, 11(10), 0-0.
     
  26. Oehler C, Scholze K, Reich H, Sander C, Hegerl U (2021). Intervention Use and Symptom Change With Unguided Internet-Based Cognitive Behavioral Therapy for Depression During the COVID-19 Pandemic: Log Data Analysis of a Convenience Sample. JMIR Ment Health, 8(7), 0-0.
     
  27. Mergl R, Dogan-Sander E, Willenberg A, Wirkner K, Kratzsch J, Riedel-Heller S, Allgaier AK, Hegerl U, Sander C (2021). The effect of depressive symptomatology on the association of vitamin D and sleep. BMC Psychiatry, 21(1), 178.
     
  28. Oehler C, Scholze K, Driessen P, Rummel-Kluge C, Görges F, Hegerl U (2021). How are guide profession and routine care setting related to adherence and symptom change in iCBT for depression? - an explorative log-data analysis. Internet Interv, 26(), 0-0.
     
  29. Dogan-Sander E, Kohls E, Baldofski S, Rummel-Kluge C (2021). More Depressive Symptoms, Alcohol and Drug Consumption: Increase in Mental Health Symptoms Among University Students After One Year of the COVID-19 Pandemic. Front Psychiatry, 12(), 790974.
     
  30. Wittekind DA, Kratzsch J, Mergl R, Baber R, Witte V, Villringer A, Kluge M (2021). Free triiodothyronine (T3) is negatively associated with fasting ghrelin serum levels in a population sample of euthyroid subjects. J Endocrinol Invest, 44, 2655-2664.
     
  31. Dogan-Sander E, Baldofski S, Mauche N, Bot M, Brouwer IA, Cabout M, Gili M, van Grootheest G, Hegerl U, Owens M, Penninx B, Roca M, Visser M, Watkins E, Kohls E, (2021). Overweight and obese individuals with depressive symptoms from the MooDFOOD prevention trial: Role of sociodemographic, somatic health, and weight related factors Journal of Affective Disorders Reports, 4, 100126.
     
  32. Oehler C, Görges F, Hegerl U, Rummel-Kluge C (2021). A closer look at negative effects in a guided web-based intervention for mild to moderate depression Clinical Psychology: Science and Practice, 28, 131-141.
     
  33. Dittrich D, Dernbach K, Speerforck S, Schindler S, Häusser JA, Schomerus G (2021). Testing the mixed-blessings model: What is the role of essentialism for stigmatizing attitudes towards schizophrenia? Current Psychology, 0, 0-0.
     
  34. Ulke C, Fleischer T, Muehlan H, Altweck L, Hahm S, Glaesmer H, Fegert JM, Zenger M, Grabe HJ, Schmidt S, Beutel ME, Schomerus G, Brähler E, Speerforck S (2021). Socio-political context as determinant of childhood maltreatment: a population-based study among women and men in East and West Germany. Epidemiology and Psychiatric Sciences, 30, 1-8.
     
  35. Tibubos AN, Otten D, Zöller D, Binder H, Wild PS, Fleischer T, Johar H, Atasoy S, Schulze L, Ladwig KH, Schomerus G, Linkohr B, Grabe HJ, Kruse J, Schmidt CO, Münzel T, König J, Brähler E, Beutel ME (2021). Bidimensional structure and measurement equivalence of the Patient Health Questionnaire-9: sex-sensitive assessment of depressive symptoms in three representative German cohort studies. BMC Psychiatry, 21, 238.
     
  36. Altweck L, Hahm S, Muehlan H, Gfesser T, Ulke C, Speerforck S, Schomerus G, Beutel ME, Brähler E, Schmidt S (2021). The interplay of gender, social context, and long-term unemployment effects on subjective health trajectories. BMC Public Health, 21, 290.
     
  37. Vreijling SR, Penninx BWJH, Bot M, Watkins E, Owens M, Kohls E, Hegerl U, Roca M, Gili M, Brouwer IA, Visser M, Beekman ATF, Jansen R, Lamers F (2021). Effects of dietary interventions on depressive symptom profiles: results from the MooDFOOD depression prevention study. Psychol Med, 0, 1-10.
     
  38. Surova G, Ulke C, Schmidt FM, Hensch T, Sander C, Hegerl U (2021). Fatigue and brain arousal in patients with major depressive disorder. Eur Arch Psychiatry Clin Neurosci, 271, 527-536.
     
  39. Greffin K, Muehlan H, van den Berg N, Hoffmann W, Ritter O, Oeff M, Schomerus G, Schmidt S (2021). Setting-Sensitive Conceptualization and Assessment of Quality of Life in Telemedical Care-Study Protocol of the Tele-QoL Project. Int J Environ Res Public Health, 18, 10454.
     
  40. Greffin K, Schmidt S, van den Berg N, Hoffmann W, Ritter O, Oeff M, Schomerus G, Muehlan H (2021). Same same-but different: using qualitative studies to inform concept elicitation for quality of life assessment in telemedical care: a request for an extended working model. Health Qual Life Outcomes, 19, 175.
     
  41. O'Donnell A, Schulte B, Manthey J, Schmidt CS, Piazza M, Chavez IB, Natera G, Aguilar NB, Hernández GYS, Mejía-Trujillo J, Pérez-Gómez A, Gual A, de Vries H, Solovei A, Kokole D, Kaner E, Kilian C, Rehm J, Anderson P, Jané-Llopis E (2021). Primary care-based screening and management of depression amongst heavy drinking patients: Interim secondary outcomes of a three-country quasi-experimental study in Latin America. PLoS One, 16, 0255594.
     
  42. Anderson P, Manthey J, Llopis EJ, Rey GN, Bustamante IV, Piazza M, Aguilar PSM, Mejía-Trujillo J, Pérez-Gómez A, Rowlands G, Lopez-Pelayo H, Mercken L, Kokole D, O'Donnell A, Solovei A, Kaner E, Schulte B, de Vries H, Schmidt C, Gual A, Rehm J (2021). Impact of Training and Municipal Support on Primary Health Care-Based Measurement of Alcohol Consumption in Three Latin American Countries: 5-Month Outcome Results of the Quasi-experimental Randomized SCALA Trial. J Gen Intern Med, 36, 2663-2671.
     
  43. Kilian C, Manthey J, Carr S, Hanschmidt F, Rehm J, Speerforck S, Schomerus G (2021). Stigmatization of people with alcohol use disorders: An updated systematic review of population studies. Alcohol Clin Exp Res, 45, 899-911.
     
  44. Greissl S, Mergl R, Sander C, Hensch T, Engel C, Hegerl U (2021). Is unemployment associated with inefficient sleep habits? A cohort study using objective sleep measurements. J Sleep Res, (), 0-0.
     
  45. Smit DJA, Andreassen OA, Boomsma DI, Burwell SJ, Chorlian DB, de Geus EJC, Elvsåshagen T, Gordon RL, Harper J, Hegerl U, Hensch T, Iacono WG, Jawinski P, Jönsson EG, Luykx JJ, Magne CL, Malone SM, Medland SE, Meyers JL, Moberget T, Porjesz B, Sander C, Sisodiya SM, Thompson PM, van Beijsterveldt CEM, van Dellen E, Via M, Wright MJ (2021). Large-scale collaboration in ENIGMA-EEG: A perspective on the meta-analytic approach to link neurological and psychiatric liability genes to electrophysiological brain activity. Brain Behav, 11(8), 0-0.
     
  46. McLaren T, Peter LJ, Tomczyk S, Muehlan H, Stolzenburg S, Schomerus G, Schmidt S (2021). How can the utilisation of help for mental disorders be improved? A quasi-experimental online study on the changeability of stigmatising attitudes and intermediate variables in the process of utilisation. BMC Public Health, 21(1), 2124.
     
  47. Suslow T, Günther V, Hensch T, Kersting A, Bodenschatz CM (2021). Alexithymia Is Associated With Deficits in Visual Search for Emotional Faces in Clinical Depression. Front Psychiatry, 12, 668019.
     
  48. Kumral D, Cesnaite E, Beyer F, Hofmann SM, Hensch T, Sander C, Hegerl U, Haufe S, Villringer A, Witte AV, Nikulin VV (2021). Relationship between regional white matter hyperintensities and alpha oscillations in older adults. Neurobiol Aging, 112, 1-11.
     
  49. Owens M, Watkins E, Bot M, Brouwer IA, Roca M, Kohls E, Penninx BWJH, van Grootheest G, Hegerl U, Gili M, Visser M (2021). Habitual Behavior as a Mediator Between Food-Related Behavioral Activation and Change in Symptoms of Depression in the MooDFOOD Trial. Clin Psychol Sci, 9, 649-665.
     
  50. McLaren T, Peter LJ, Tomczyk S, Muehlan H, Stolzenburg S, Schomerus G, Schmidt S (2021). How can the utilisation of help for mental disorders be improved? A quasi-experimental online study on the changeability of stigmatising attitudes and intermediate variables in the process of utilisation. BMC Public Health, 21, 2124.
     
  51. Hensch T, Strobel A (2021). Differentiellpsychologische Perspektive in der Klinischen Psychologie. In: Hoyer J, Knappe S, Klinische Psychologie & Psychotherapie (S. 189-212), Berlin: Springer Verlag.
     


  52. 2020


  53. Ulke C, Surova G, Sander C, Engel C, Wirkner K, Jawinski P, Hensch T, Hegerl U (2020). Fatigue in Cancer and Neuroinflammatory and Autoimmune Disease: CNS Arousal Matters. Brain Sci, 10, 569.
     
  54. Tomczyk S, Schmidt S, Muehlan H, Stolzenburg S, Schomerus G (2020). A Prospective Study on Structural and Attitudinal Barriers to Professional Help-Seeking for Currently Untreated Mental Health Problems in the Community. J Behav Health Serv Res, 47, 54-69.
     
  55. Görges F, Gravert C, Rummel-Kluge C, Hegerl U (2020). [Info-Telefon Depression-An exploratory analysis of data from callers to a German information hotline for depression]. Nervenarzt, 91, 1050-1053.
     
  56. Stibbe T, Huang J, Paucke M, Ulke C, Strauß M (2020). Gender differences in adult ADHD: Cognitive function assessed by the test of attentional performance. PLoS One, 15, 0240810.
     
  57. Strauß M, Reif A, Ulke C, Paucke M, Sander C, Hegerl U, Weber H, Heupel J, Kopf J, Kittel-Schneider S (2020). Is brain arousal regulation a predictor of response to psychostimulant therapy in adult ADHD patients? Eur Arch Psychiatry Clin Neurosci, 270, 1073-1076.
     
  58. Strauß M, Petroff D, Huang J, Ulke C, Paucke M, Bogatsch H, Böhme P, Hoffmann K, Reif A, Kittel-Schneider S, Heuser I, Ahlers E, Gallinat J, Schöttle D, Fallgatter A, Ethofer T, Unterecker S, Hegerl U (2020). The "VIP-ADHD trial": Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients? Eur Neuropsychopharmacol, x, 0-0.
     
  59. Polyakova M, Beyer F, Mueller K, Sander C, Witte V, Lampe L, Rodrigues F, Riedel-Heller S, Kratzsch J, Hoffmann KT, Villringer A, Schoenknecht P, Schroeter ML (2020). Serum BDNF levels correlate with regional cortical thickness in minor depression: a pilot study. Sci Rep, 10, 14524.
     
  60. Schmidt FM, Mergl R, Minkwitz J, Holdt LM, Teupser D, Hegerl U, Himmerich H, Sander C (2020). Is There an Association or Not?-Investigating the Association of Depressiveness, Physical Activity, Body Composition and Sleep With Mediators of Inflammation. Front Psychiatry, 11, 563.
     
  61. Lorenz N, Sander C, Ivanova G, Hegerl U (2020). Temporal Associations of Daily Changes in Sleep and Depression Core Symptoms in Patients Suffering From Major Depressive Disorder: Idiographic Time-Series Analysis. JMIR Ment Health, 7, 17071.
     
  62. Wittekind DA, Kratzsch J, Mergl R, Enzenbach C, Witte V, Villringer A, Kluge M (2020). Higher fasting ghrelin serum levels in active smokers than in former and never-smokers. World J Biol Psychiatry, 21, 748-756.
     
  63. Marizzoni M, Ferrari C, Babiloni C, Albani D, Barkhof F, Cavaliere L, Didic M, Forloni G, Fusco F, Galluzzi S, Hensch T, Jovicich J, Marra C, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ranjeva JP, Ribaldi F, Rolandi E, Rossini PM, Salvatore M, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB (2020). CSF cutoffs for MCI due to AD depend on APOE?4 carrier status. Neurobiol Aging, 89, 55-62.
     
  64. Näher AF, Rummel-Kluge C, Hegerl U (2020). Associations of Suicide Rates With Socioeconomic Status and Social Isolation: Findings From Longitudinal Register and Census Data. Front Psychiatry, 10, 898.
     
  65. Quattrini G, Pievani M, Jovicich J, Aiello M, Bargalló N, Barkhof F, Bartres-Faz D, Beltramello A, Pizzini FB, Blin O, Bordet R, Caulo M, Constantinides M, Didic M, Drevelegas A, Ferretti A, Fiedler U, Floridi P, Gros-Dagnac H, Hensch T, Hoffmann KT, Kuijer JP, Lopes R, Marra C, Müller BW, Nobili F, Parnetti L, Payoux P, Picco A, Ranjeva JP, Roccatagliata L, Rossini PM, Salvatore M, Schonknecht P, Schott BH, Sein J, Soricelli A, Tarducci R, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Frison (2020). Amygdalar nuclei and hippocampal subfields on MRI: Test-retest reliability of automated volumetry across different MRI sites and vendors. Neuroimage, 218, 116932.
     
  66. Tomczyk S, Schomerus G, Stolzenburg S, Muehlan H, Schmidt S (2020). Ready, Willing and Able? An Investigation of the Theory of Planned Behaviour in Help-Seeking for a Community Sample with Current Untreated Depressive Symptoms. Prev Sci, 21, 749-760.
     
  67. Oehler C, Görges F, Rogalla M, Rummel-Kluge C, Hegerl U (2020). Efficacy of a Guided Web-Based Self-Management Intervention for Depression or Dysthymia: Randomized Controlled Trial With a 12-Month Follow-Up Using an Active Control Condition. J Med Internet Res, 22, 15361.
     
  68. Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Gaebel W, Verde PE, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl T, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Wobrock T, Cordes J (2020). A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design. Eur Arch Psychiatry Clin Neurosci, 270, 83-94.
     
  69. Otte C, Chae WR, Nowacki J, Kaczmarczyk M, Piber D, Roepke S, Märschenz S, Lischewski S, Schmidt S, Ettrich B, Grabe HJ, Hegerl U, Hinkelmann K, Hofmann T, Janowitz D, Junghanns K, Kahl KG, Klein JP, Krueger THC, Leicht G, Prvulovic D, Reif A, Schoettle D, Strauß M, Westermair A, Friede T, Gold SM (2020). Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open, 10, 040119.
     
  70. Pérez-Ara MÁ, Gili M, Visser M, Penninx BWJH, Brouwer IA, Watkins E, Owens M, García-Toro M, Hegerl U, Kohls E, Bot M, Roca M (2020). Associations of Non-Alcoholic Beverages with Major Depressive Disorder History and Depressive Symptoms Clusters in a Sample of Overweight Adults. Nutrients, 12, 3202.
     
  71. Thesing CS, Milaneschi Y, Bot M, Brouwer IA, Owens M, Hegerl U, Gili M, Roca M, Kohls E, Watkins E, Visser M, Penninx BWJH (2020). Supplementation-induced increase in circulating omega-3 serum levels is not associated with a reduction in depressive symptoms: Results from the MooDFOOD depression prevention trial. Depress Anxiety, 37, 1079-1088.
     
  72. Owens M, Watkins E, Bot M, Brouwer IA, Roca M, Kohls E, Penninx B, van Grootheest G, Cabout M, Hegerl U, Gili M, Visser M (2020). Acceptability and feasibility of two interventions in the MooDFOOD Trial: a food-related depression prevention randomised controlled trial in overweight adults with subsyndromal symptoms of depression. BMJ Open, 10, 034025.
     
  73. Paans NPG, Bot M, Brouwer IA, Visser M, Gili M, Roca M, Hegerl U, Kohls E, Owens M, Watkins E, Penninx BWJH (2020). Effects of food-related behavioral activation therapy on eating styles, diet quality and body weight change: Results from the MooDFOOD Randomized Clinical Trial. J Psychosom Res, 137, 110206.
     
  74. Owens M, Watkins E, Bot M, Brouwer I Roca M, Kohls E, Penninx B, van Grootheest G, Hegerl U, Gili M, Visser M (2020). Nutrition and depression: Summary of?ndings from the EU-funded MooDFOODdepression prevention randomised controlledtrial and a critical review of the literature Nutrition Bulletin, 45, 403-414.
     
  75. Losert A, Sander C, Schredl M, Heilmann-Etzbach I, Deuschle M, Hegerl U, Schilling C (2020). Enhanced Vigilance Stability during Daytime in Insomnia Disorder. Brain Sci, 10, 830.
     
  76. Treml J, Linde K, Engel C, Glaesmer H, Hinz A, Luck T, Riedel-Heller S, Sander C, Kersting A (2020). Loss and grief in elderly people: Results from the LIFE-Adult-Study. Death Stud, 0, 1-10.
     
  77. Minkwitz J, Sander C, Himmerich H, Thormann J, Chittka T, Hegerl U, Schmidt F, Murray M, Albayrak N, Campbell IC, Scheipl F (2020). Reported and Recorded Sleepiness in Obesity and Depression. Front Psychiatry, 11, 200.
     
  78. Surova G, Ulke C, Schmidt FM, Hensch T, Sander C, Hegerl U (2020). Fatigue and brain arousal in patients with major depressive disorder. Eur Arch Psychiatry Clin Neurosci, 0, 0-0.
     
  79. Hensch T, Strobel A (2020). Differentiellpsychologische Perspektive in der Klinischen Psychologie. In: Hoyer J, Knappe S , Klinische Psychologie & Psychotherapie. (S. 193-216), Berlin: Springer Verlag.
     


  80. 2019


  81. Schindler S, Schmidt L, Stroske M, Storch M, Anwander A, Trampel R, Strauss M, Hegerl U, Geyer S, Schonknecht P (2019). Hypothalamus enlargement in mood disorders. Acta Psychiatr Scand, 139(1), 56-67.
     
  82. Dogan-Sander E, Willenberg A, Batmaz I, Enzenbach C, Wirkner K, Kohls E, Mergl R, Thiery J, Kratzsch J, Hegerl U, Sander C (2019). Association of serum 25-hydroxyvitamin D concentrations with sleep phenotypes in a German community sample. PLoS One, 14, 0219318.
     
  83. Ulke C, Wittekind DA, Spada J, Franik K, Jawinski P, Hensch T, Hegerl U (2019). Brain arousal regulation in SSRI-medicated patients with major depression. J Psychiatr Res, 108, 34-39.
     
  84. Hartmann R, Sander C, Lorenz N, Böttger D, Hegerl U (2019). Utilization of Patient-Generated Data Collected Through Mobile Devices: Insights From a Survey on Attitudes Toward Mobile Self-Monitoring and Self-Management Apps for Depression. JMIR Ment Health, 6, 11671.
     
  85. Hartmann R, Schmidt FM, Sander C, Hegerl U (2019). Heart Rate Variability as Indicator of Clinical State in Depression. Front Psychiatry, 9, 735.
     
  86. Minkwitz J, Scheipl F, Cartwright L, Campbell IC, Chittka T, Thormann J, Hegerl U, Sander C, Himmerich H (2019). Why some obese people become depressed whilst others do not: exploring links between cognitive reactivity, depression and obesity. Psychol Health Med, 24, 362-373.
     
  87. Lorenz N, Spada J, Sander C, Riedel-Heller SG, Hegerl U (2019). Circadian skin temperature rhythms, circadian activity rhythms and sleep in individuals with self-reported depressive symptoms. J Psychiatr Res, 117, 38-44.
     
  88. Strauss M, Reif A, Ulke C, Paucke M, Sander C, Hegerl U, Weber H, Heupel J, Kopf J, Kittel-Schneider S (2019). Is brain arousal regulation a predictor of response to psychostimulant therapy in adult ADHD patients? Eur Arch Psychiatry Clin Neurosci, 0, 0.
     
  89. Ulke C, Rullmann M, Huang J, Luthardt J, Becker GA, Patt M, Meyer PM, Tiepolt S, Hesse S, Sabri O, Strauss M (2019). Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study. Transl Psychiatry, 9(1), 301-.
     
  90. Huang J, Ulke C, Strauss M (2019). Brain arousal regulation and depressive symptomatology in adults with attention-deficit/hyperactivity disorder (ADHD). BMC Neurosci, 20(1), 43-.
     
  91. Paucke M, Stibbe T, Huang J, Strauss M (2019). Differentiation of ADHD and Depression Based on Cognitive Performance. J Atten Disord, 0, 0.
     
  92. Hensch T, Wozniak D, Spada J, Sander C, Ulke C, Wittekind DA, Thiery J, Loffler M, Jawinski P, Hegerl U (2019). Vulnerability to bipolar disorder is linked to sleep and sleepiness. Transl Psychiatry, 9(1), 294-.
     
  93. Görges F, Oehler C, von Hirschhausen E, Hegerl U, Rummel-Kluge C (2019). GET.HAPPY2 - User perspectives on an internet-based self-management positive psychology intervention among persons with and without depression: Results from a retrospective survey. J Clin Psychol, 0, 0.
     
  94. Heinz I, Mergl R, Hegerl U, Rummel-Kluge C, Kohls E (2019). Depression stigma and management of suicidal callers: a cross-sectional survey of crisis hotline counselors. BMC Psychiatry, 19(1), 342-.
     
  95. Baldofski S, Mauche N, Dogan-Sander E, Bot M, Brouwer IA, Paans NPG, Cabout M, Gili M, van Grootheest G, Hegerl U, Owens M, Roca M, Visser M, Watkins E, Penninx BWJH, Kohls E (2019). Depressive Symptom Clusters in Relation to Body Weight Status: Results From Two Large European Multicenter Studies. Front Psychiatry, 10, 858-.
     
  96. Wittekind DA, Kratzsch J, Mergl R, Enzenbach C, Witte V, Villringer A, Kluge M (2019). Higher fasting ghrelin serum levels in active smokers than in former and never-smokers. World J Biol Psychiatry, 0, 1-9.
     
  97. Horsfield P, Stolzenburg S, Hahm S, Tomczyk S, Muehlan H, Schmidt S, Schomerus G (2019). Self-labeling as having a mental or physical illness: the effects of stigma and implications for help-seeking. Soc Psychiatry Psychiatr Epidemiol, 0, 0.
     
  98. Tomczyk S, Schmidt S, Muehlan H, Stolzenburg S, Schomerus G (2019). A Prospective Study on Structural and Attitudinal Barriers to Professional Help-Seeking for Currently Untreated Mental Health Problems in the Community. J Behav Health Serv Res, 0, 0.
     
  99. Schmidt FM, Koch J, Nowak C, Holdt LM, Teupser D, Hegerl U, Himmerich H (2019). Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy. J Psychiatr Res, 119, 116-121.
     
  100. Schmidt FM, Sander C, Walter M (2019). Editorial: Recent Advances on the Multimodal Search for Markers of Treatment Response in Affective Disorders: From Bench to Bedside? Front Psychiatry, 10, 790.
     
  101. Bot M, Brouwer IA, Roca M, Kohls E, Penninx BWJH, Watkins E, van Grootheest G, Cabout M, Hegerl U, Gili M, Owens M, Visser M (2019). Effect of Multinutrient Supplementation and Food-Related Behavioral Activation Therapy on Prevention of Major Depressive Disorder Among Overweight or Obese Adults With Subsyndromal Depressive Symptoms: The MooDFOOD Randomized Clinical Trial. JAMA, 321, 858-868.
     
  102. Marizzoni M, Ferrari C, Macis A, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Pizzini F, Rossini PM, Salvatore M, Schönknecht P, Soricelli A, Del Percio C, Hensch T, Hegerl U, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB (2019). Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease. J Alzheimers Dis, 69, 49-58.
     
  103. Jovicich J, Babiloni C, Ferrari C, Marizzoni M, Moretti DV, Del Percio C, Lizio R, Lopez S, Galluzzi S, Albani D, Cavaliere L, Minati L, Didic M, Fiedler U, Forloni G, Hensch T, Molinuevo JL, Bartres Faz D, Nobili F, Orlandi D, Parnetti L, Farotti L, Costa C, Payoux P, Rossini PM, Marra C, Schönknecht P, Soricelli A, Noce G, Salvatore M, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Frisoniand GB (2019). Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity. J Alzheimers Dis, 69, 15-35.
     
  104. Marizzoni M, Ferrari C, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ribaldi F, Rossini PM, Schönknecht P, Salvatore M, Soricelli A, Hensch T, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB (2019). Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers. J Alzheimers Dis, 69, 3-14.
     
  105. Boschloo L, Bekhuis E, Weitz ES, Reijnders M, DeRubeis RJ, Dimidjian S, Dunner DL, Dunlop BW, Hegerl U, Hollon SD, Jarrett RB, Kennedy SH, Miranda J, Mohr DC, Simons AD, Parker G, Petrak F, Herpertz S, Quilty LC, John Rush A, Segal ZV, Vittengl JR, Schoevers RA, Cuijpers P (2019). The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis. World Psychiatry, 18, 183-191.
     
  106. Furukawa TA, Reijnders M, Kishimoto S, Sakata M, DeRubeis RJ, Dimidjian S, Dozois DJA, Hegerl U, Hollon SD, Jarrett RB, Lesperance F, Segal ZV, Mohr DC, Simons AD, Quilty LC, Reynolds CF, Gentili C, Leucht S, Engel RR, Cuijpers P (2019). Translating the BDI and BDI-II into the HAMD and vice versa with equipercentile linking. Epidemiol Psychiatr Sci, 0, 1-13.
     
  107. Kramer L, Sander C, Bertsch K, Gescher DM, Cackowski S, Hegerl U, Herpertz SC (2019). EEG-vigilance regulation in Borderline Personality Disorder. Int J Psychophysiol, 139, 10-17.
     
  108. Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Gaebel W, Verde PE, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl T, Reske D, Gouzoulis-Mayfrank E, Grunder G, Hasan A, Brockhaus-Dumke A, Jager M, Baumgartner J, Wobrock T, Cordes J (2019). A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design. Eur Arch Psychiatry Clin Neurosci, 0, 0.
     
  109. Grasso AC, Olthof MR, van Dooren C, Roca M, Gili M, Visser M, Cabout M, Bot M, Penninx BWJH, van Grootheest G, Kohls E, Hegerl U, Owens M, Watkins E, Brouwer IA (2019). Effect of food-related behavioral activation therapy on food intake and the environmental impact of the diet: results from the MooDFOOD prevention trial. Eur J Nutr, 0, 0.
     
  110. Thomas K, Beyer F, Lewe G, Zhang R, Schindler S, Schonknecht P, Stumvoll M, Villringer A, Witte AV (2019). Higher body mass index is linked to altered hypothalamic microstructure. Sci Rep, 9(1), 17373-.
     
  111. Minkwitz J, Scheipl F, Cartwright L, Campbell IC, Chittka T, Thormann J, Hegerl U, Sander C, Himmerich H (2019). Why some obese people become depressed whilst others do not: exploring links between cognitive reactivity, depression and obesity. Psychol Health Med, 24(3), 362-373.
     
  112. Frase L, Acker J, Cohrs S, Danker-Hopfe H, Frohn C, Goder R, Mauche N, Norra C, Pollmacher T, Richter K, Riemann D, Schilling C, Weess HG, Wetter TC, Nissen C (2019). Recommendations on performing polygraphy or polysomnography in the fields of psychiatry and psychotherapy : Position paper of the working group on sleep medicine of the German Association for Psychiatry, Psychotherapy and Psychosomatics. Nervenarzt, 0, 0.
     


  113. 2018


  114. Schmidt FM, Sander C, Minkwitz J, Mergl R, Dalton B, Holdt LM, Teupser D, Hegerl U, Himmerich H (2018). Serum Markers of Inflammation Mediate the Positive Association Between Neuroticism and Depression. Front Psychiatry, 9, 609.
     
  115. Hegerl U, Mergl R, Sander C, Dietzel J, Bitter I, Demyttenaere K, Gusmao R, Arrillaga AG, Zorrilla I, Alocen AG, Sola VP, Vieta E, Juckel G, Zimmermann US, Bauer M, Sienaert P, Quintao S, Edel MA, Bolyos C, Ayuso-Mateos JL, Lopez-Garcia P, Kluge M (2018). A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study). Eur Neuropsychopharmacol, 28(1), 185-194.
     
  116. Hegerl U, Heinz I (2018). Reflections on causes of suicidal behaviour. Epidemiol Psychiatr Sci, 0, 1-4.
     
  117. Hegerl U, Mergl R, Sander C, Dietzel J, Bitter I, Demyttenaere K, Gusmao R, Arrillaga AG, Zorrilla I, Alocen AG, Sola VP, Vieta E, Juckel G, Zimmermann US, Bauer M, Sienaert P, Quintao S, Edel MA, Bolyos C, Ayuso-Mateos JL, Lopez-Garcia P, Kluge M (2018). A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study). Eur Neuropsychopharmacol, 28(1), 185-194.
     
  118. Schindler S, Schmidt L, Stroske M, Storch M, Anwander A, Trampel R, Strauß M, Hegerl U, Geyer S, Schönknecht P (2018). Hypothalamus enlargement in mood disorders. Acta Psychiatr Scand, 0, 0.
     
  119. Ulke C, Tenke CE, Kayser J, Sander C, Böttger D, Wong LYX, Alvarenga JE, Fava M, McGrath PJ, Deldin PJ, Mcinnis MG, Trivedi MH, Weissman MM, Pizzagalli DA, Hegerl U, Bruder GE (2018). Resting EEG Measures of Brain Arousal in a Multisite Study of Major Depression. Clin EEG Neurosci, 0, 0.
     
  120. Görges F, Oehler C, von Hirschhausen E, Hegerl U, Rummel-Kluge C (2018). GET.HAPPY - Acceptance of an internet-based self-management positive psychology intervention for adult primary care patients with mild and moderate depression or dysthymia: A pilot study. Internet Interv, 12, 26-35.
     
  121. Paucke M, Stark T, Exner C, Kallweit C, Hegerl U, Strauß M (2018). [Attention deficit-hyperactivity disorder (ADHD) and comorbid mental disorders : ADHD-specific self-rating scales in differential diagnostics]. Nervenarzt, 0, 0.
     
  122. Wolff J, Schindler S, Lucas C, Binninger AS, Weinrich L, Schreiber J, Hegerl U, Möller HE, Leitzke M, Geyer S, Schönknecht P (2018). A semi-automated algorithm for hypothalamus volumetry in 3 Tesla magnetic resonance images. Psychiatry Res Neuroimaging, 277, 45-51.
     
  123. Jawinski P, Kirsten H, Sander C, Spada J, Ulke C, Huang J, Burkhardt R, Scholz M, Hensch T, Hegerl U (2018). Human brain arousal in the resting state: a genome-wide association study. Mol Psychiatry, 0, 0.
     
  124. Huang J, Ulke C, Sander C, Jawinski P, Spada J, Hegerl U, Hensch T (2018). Impact of brain arousal and time-on-task on autonomic nervous system activity in the wake-sleep transition. BMC Neurosci, 19, 18.
     
  125. Mergl R, Allgaier AK, Hautzinger M, Coyne JC, Hegerl U, Henkel V (2018). One-year follow-up of a randomized controlled trial of sertraline and cognitive behavior group therapy in depressed primary care patients (MIND study). J Affect Disord, 230, 15-21.
     
  126. Ulke C, Mauche N, Makiol C, Bednasch K, Wittekind DA, Hegerl U, Strauß M (2018). Successful treatment in a case of ultra-rapid cycling bipolar disorder is reflected in brain arousal regulation. Bipolar Disord, 20, 77-80.
     
  127. Strauß M, Ulke C, Paucke M, Huang J, Mauche N, Sander C, Stark T, Hegerl U (2018). Brain arousal regulation in adults with attention-deficit/hyperactivity disorder (ADHD). Psychiatry Res, 261, 102-108.
     
  128. Coppens E, Van Audenhove C, Gusmao R, Purebl G, Szekely A, Maxwell M, Koburger N, Arensman E, Hegerl U (2018). Effectiveness of General Practitioner training to improve suicide awareness and knowledge and skills towards depression. J Affect Disord, 227, 17-23.
     
  129. Wittekind DA, Kratzsch J, Mergl R, Enzenbach C, Witte AV, Villringer A, Kluge M (2018). Alcohol consumption is positively associated with fasting serum ghrelin in non-dependent adults: Results from the population-based LIFE-Adult-Study. Psychoneuroendocrinology, 97, 143-148.
     
  130. Sander C, Schmidt JM, Mergl R, Schmidt FM, Hegerl U (2018). Changes in brain arousal (EEG-vigilance) after therapeutic sleep deprivation in depressive patients and healthy controls. Sci Rep, 8, 15087.
     
  131. Strauß M, Mergl R, Gürke N, Kleinert K, Sander C, Hegerl U (2018). Association between acute critical life events and the speed of onset of depressive episodes in male and female depressed patients. BMC Psychiatry, 18, 332.
     
  132. Schmidt FM (2018). Cognitive behaviour therapy and inflammation: A systematic review of its relationship and the potential implications for the treatment of depression. Aust N Z J Psychiatry, 52, 385-386.
     
  133. Sabri O, Meyer PM, Gräf S, Hesse S, Wilke S, Becker GA, Rullmann M, Patt M, Luthardt J, Wagenknecht G, Hoepping A, Smits R, Franke A, Sattler B, Tiepolt S, Fischer S, Deuther-Conrad W, Hegerl U, Barth (2018). Cognitive correlates of ?4?2 nicotinic acetylcholine receptors in mild Alzheimer's dementia. Brain, 141, 1840-1854.
     
  134. Beesdo-Baum K, Knappe S, Einsle F, Knothe L, Wieder G, Venz J, Rummel-Kluge C, Heinz I, Koburger N, Schouler-Ocak M, Wilbertz T, Unger HP, Walter U, Hein J, Hegerl U, Lieb R, Pfennig A, Schmitt J, Hoy (2018). [How frequently are depressive disorders recognized in primary care patients? : A cross-sectional epidemiological study in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 61, 52-64.
     
  135. Wolff J, Schindler S, Lucas C, Binninger AS, Weinrich L, Schreiber J, Hegerl U, Moller HE, Leitzke M, Geyer S, Schonknecht P (2018). A semi-automated algorithm for hypothalamus volumetry in 3 Tesla magnetic resonance images. Psychiatry Res Neuroimaging, 277, 45-51.
     


  136. 2017


  137. Schmidt FM, Schindler S, Adamidis M, Strauss M, Trankner A, Trampel R, Walter M, Hegerl U, Turner R, Geyer S, Schonknecht P (2017). Habenula volume increases with disease severity in unmedicated major depressive disorder as revealed by 7T MRI. Eur Arch Psychiatry Clin Neurosci, 267(2), 107-115.
     
  138. Ulke C, Sander C, Jawinski P, Mauche N, Huang J, Spada J, Wittekind D, Mergl R, Luck T, Riedel-Heller S, Hensch T, Hegerl U (2017). Sleep disturbances and upregulation of brain arousal during daytime in depressed versus non-depressed elderly subjects. World J Biol Psychiatry, 18(80), 633-640.
     
  139. Arensman E, Coffey C, Griffin E, Van Audenhove C, Scheerder G, Gusmao R, Costa S, Larkin C, Koburger N, Maxwell M, Harris F, Postuvan V, Hegerl U (2017). Effectiveness of Depression-Suicidal Behaviour Gatekeeper Training among police officers in three European regions: Outcomes of the Optimising Suicide Prevention Programmes and Their Implementation in Europe (OSPI-Europe) study. Int J Soc Psychiatry, 00, 00.
     
  140. Dietrich S, Mergl R, Rummel-Kluge C (2017). [From the First Symptoms of Depression to Treatment. When and Where are People Seeking Help? Does Stigma Play a Role?] Psychiatr Prax, 44(8), 461-468.
     
  141. Dogan E, Sander C, Wagner X, Hegerl U, Kohls E (2017). Smartphone-Based Monitoring of Objective and Subjective Data in Affective Disorders: Where Are We and Where Are We Going? Systematic Review. J Med Internet Res, 19, e262.
     
  142. Pfeil S, Holtz K, Kopf KA, Hegerl U, Rummel-Kluge C (2017). Minor depression in older, long-term unemployed people seeking vocational support. BMC Psychiatry, 17(1), 243.
     
  143. Freeman A, Mergl R, Kohls E, Szekely A, Gusmao R, Arensman E, Koburger N, Hegerl U, Rummel-Kluge C (2017). A cross-national study on gender differences in suicide intent. BMC Psychiatry, 17(1), 234.
     
  144. Jawinski P, Kittel J, Sander C, Huang J, Spada J, Ulke C, Wirkner K, Hensch T, Hegerl U (2017). Recorded and Reported Sleepiness: The Association Between Brain Arousal in Resting State and Subjective Daytime Sleepiness. Sleep, 40(7), zsx099.
     
  145. Kohls E, Coppens E, Hug J, Wittevrongel E, Van Audenhove C, Koburger N, Arensman E, Szekely A, Gusmao R, Hegerl U (2017). Public attitudes toward depression and help-seeking: Impact of the OSPI-Europe depression awareness campaign in four European regions. J Affect Disord, 217, 252-259.
     
  146. Schmidt FM, Sander C, Dietz ME, Nowak C, Schroder T, Mergl R, Schonknecht P, Himmerich H, Hegerl U (2017). Brain arousal regulation as response predictor for antidepressant therapy in major depression. Sci Rep, 7, 45187.
     
  147. Hinz A, Glaesmer H, Brahler E, Loffler M, Engel C, Enzenbach C, Hegerl U, Sander C (2017). Sleep quality in the general population: psychometric properties of the Pittsburgh Sleep Quality Index, derived from a German community sample of 9284 people. Sleep Med, 30, 57-63.
     
  148. Sander C, Ueck P, Mergl R, Gordon G, Hegerl U, Himmerich H (2017). Physical activity in depressed and non-depressed patients with obesity. Eat Weight Disord, 0, 0.
     
  149. Huang J, Hensch T, Ulke C, Sander C, Spada J, Jawinski P, Hegerl U (2017). Evoked potentials and behavioral performance during different states of brain arousal. BMC Neurosci, 7(1), 11804.
     
  150. Hegerl U, Hensch T (2017). Why do stimulants not work in typical depression? Aust N Z J Psychiatry, 51(1), 20-22.
     
  151. Coppens E, Van Audenhove C, Gusmao R, Purebl G, Szekely A, Maxwell M, Koburger N, Arensman E, Hegerl U (2017). Effectiveness of General Practitioner training to improve suicide awareness and knowledge and skills towards depression. J Affect Disord, 227, 17-23.
     
  152. Koburger N, Hegerl U (2017). Onlineselbstmanagement: Ergänzung zur Depressionsbehandlung. Deutsches Ärzteblatt, 114(25), A1252.
     
  153. Strauß M, Ulke C, Paucke M, Huang J, Mauche N, Sander C, Stark T, Hegerl U (2017). Brain arousal regulation in adults with attention-deficit/hyperactivity disorder (ADHD). Psychiatry Res, 261, 102-108.
     
  154. Paul E, Mergl R, Hegerl U (2017). Has information on suicide methods provided via the Internet negatively impacted suicide rates? PLoS One, 12(12), e0190136.
     
  155. Ulke C, Huang J, Schwabedal JTC, Surova G, Mergl R, Hensch T (2017). Coupling and dynamics of cortical and autonomic signals are linked to central inhibition during the wake-sleep transition. Sci Rep, 7(1), 11804.
     
  156. Schindler S, Schreiber J, Bazin PL, Trampel R, Anwander A, Geyer S, Schönknecht P (2017). Intensity standardisation of 7T MR images for intensity-based segmentation of the human hypothalamus. PLoS One, 12(3), e0173344.
     
  157. Konte B, Leicht G, Giegling I, Pogarell O, Karch S, Hartmann AM, Friedl M, Hegerl U, Rujescu D, Mulert C (2017). A genome-wide association study of early gamma-band response in a schizophrenia case-control sample. World J Biol Psychiatry, 0, 0.
     
  158. Hallensleben N, Spangenberg L, Forkmann T, Rath D, Hegerl U, Kersting A, Kallert TW, Glaesmer H (2017). Investigating the Dynamics of Suicidal Ideation. Crisis, 0, 0-0.
     
  159. Justicia A, Elices M, Cebria AI, Palao DJ, Gorosabel J, Puigdemont D, de Diego-Adelino J, Gabilondo A, Iruin A, Hegerl U, Perez V (2017). Rationale and methods of the iFightDepression study: A double-blind, randomized controlled trial evaluating the efficacy of an internet-based self-management tool for moderate to mild depression. BMC Psychiatry, 17(1), 143.
     
  160. Gold SM, Enck P, Hasselmann H, Friede T, Hegerl U, Mohr DC, Otte C (2017). Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. Lancet Psychiatry, 4(9), 725-732.
     
  161. Zalsman G, Hawton K, Wasserman D, van Heeringen K, Arensman E, Sarchiapone M, Carli V, Hoschl C, Winkler P, Balazs J, Purebl G, Kahn JP, Saiz PA, Bobes J, Cozman D, Hegerl U, Rancans E, Hadlaczky G, V (2017). Evidence-based national suicide prevention taskforce in Europe: A consensus position paper. Eur Neuropsychopharmacol, 27(4), 418-421.
     
  162. Liu NH, Daumit GL, Dua T, Aquila R, Charlson F, Cuijpers P, Druss B, Dudek K, Freeman M, Fujii C, Gaebel W, Hegerl U, Levav I, Munk Laursen T, Ma H, Maj M, Elena Medina-Mora M, Nordentoft M, Prabhakar (2017). Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry, 16(1), 30-40.
     
  163. Furukawa TA, Weitz ES, Tanaka S, Hollon SD, Hofmann SG, Andersson G, Twisk J, DeRubeis RJ, Dimidjian S, Hegerl U, Mergl R, Jarrett RB, Vittengl JR, Watanabe N, Cuijpers P (2017). Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials. Br J Psychiatry, 210(3), 190-196.
     
  164. Trautmann S, Beesdo-Baum K, Knappe S, Einsle F, Knothe L, Wieder G, Venz J, Rummel-Kluge C, Heinz I, Koburger N, Schouler-Ocak M, Wilbertz T, Unger H-P, Walter U, Hein J, Hegerl U, Lieb R, Pfennig A, (2017). The treatment of depression in primary care - a cross-sectional epidemiological study. Deutsches Ärzteblatt International, 114(43), 721-728.
     
  165. Nathan PJ, Lim YY, Abbott R, Galluzzi S, Marizzoni M, Babiloni C, Albani D, Bartres-Faz D, Didic M, Farotti L, Parnetti L, Salvadori N, Muller BW, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A (2017). Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI). Neurobiol Aging, 53, 1-10.
     
  166. Wolfersdorf M, Hegerl U (2017). Suizid und Suizidalität. In: Voderholzer U, Hohagen F, Therapie psychischer Erkrankungen. State of the Art. (S. 471-476), München: Urban & Fischer.
     
  167. Rummel-Kluge C, Hegerl U (2017). Depressions- und Suizidprävention. In: Klosterkötter J, Maier W, Handbuch Präventive Psychiatrie. (S. 197-210), Stuttgart: Schattauer.
     
  168. Aleithe M, Hegerl U, Ivanova G (2017). An architectural model for high performance pattern matching in linked historical data In: Abramowicz W, Alt R, Franczyk B, Business Information Systems Workshops (S. 323-331), Cham: Springer.
     


  169. 2016


  170. Hegerl U, Kohls E (2016). Synergistic effects of multi-level suicide preventive interventions: Important, but difficult to disentangle. Aust N Z J Psychiatry, 50(2), 178-179.
     
  171. Schmidt FM, Pschiebl A, Sander C, Kirkby KC, Thormann J, Minkwitz J, Chittka T, Weschenfelder J, Holdt LM, Teupser D, Hegerl U, Himmerich H (2016). Impact of Serum Cytokine Levels on EEG-Measured Arousal Regulation in Patients with Major Depressive Disorder and Healthy Controls. Neuropsychobiology, 73(1), 1-9.
     
  172. Hegerl U, Rummel-Kluge C, Heinz I (2016). [From the Competence Network on Depression and Suicidality to the German Depression Foundation. National and international prevention of suicidal behaviour and optimizing health care through using of E-Mental-Health]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 59(4), 406-411.
     
  173. Harris FM, Maxwell M, O Connor R, Coyne JC, Arensman E, Coffey C, Koburger N, Gusmao R, Costa S, Szekely A, Cserhati Z, McDaid D, van Audenhove C, Hegerl U (2016). Exploring synergistic interactions and catalysts in complex interventions: longitudinal, mixed methods case studies of an optimised multi-level suicide prevention intervention in four european countries (Ospi-Europe). BMC Public Health, 16, 268.
     
  174. Jawinski P, Mauche N, Ulke C, Huang J, Spada J, Enzenbach C, Sander C, Hegerl U, Hensch T (2016). Tobacco use is associated with reduced amplitude and intensity dependence of the cortical auditory evoked N1-P2 component. Psychopharmacology (Berl), 233(11), 2173-2183.
     
  175. Spada J, Scholz M, Kirsten H, Hensch T, Horn K, Jawinski P, Ulke C, Burkhardt R, Wirkner K, Loeffler M, Hegerl U, Sander C (2016). Genome-wide association analysis of actigraphic sleep phenotypes in the LIFE Adult Study. J Sleep Res, 25(6), 690-701.
     
  176. Schmidt FM, Schröder T, Kirkby KC, Sander C, Suslow T, Holdt LM, Teupser D, Hegerl U, Himmerich H (2016). Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression. Psychiatry Res, 239, 85-91.
     
  177. Jawinski P, Tegelkamp S, Sander C, Hantzsch M, Huang J, Mauche N, Scholz M, Spada J, Ulke C, Burkhardt R, Reif A, Hegerl U, Hensch T (2016). Time to wake up: No impact of COMT Val158Met gene variation on circadian preferences, arousal regulation and sleep. Chronobiol Int, 33(7), 893-905.
     
  178. Hegerl U (2016). The power of words in psychiatry. Aust N Z J Psychiatry, 50(7), 695.
     
  179. Sander C, Hegerl U, Wirkner K, Walter N, Kocalevent RD, Petrowski K, Glaesmer H, Hinz A (2016). Normative values of the Epworth Sleepiness Scale (ESS), derived from a large German sample. Sleep Breath, 20(4), 1337-1345.
     
  180. Hegerl U (2016). Prevention of suicidal behavior. Dialogues Clin Neurosci, 18(2), 183-190.
     
  181. Wittekind DA, Spada J, Gross A, Hensch T, Jawinski P, Ulke C, Sander C, Hegerl U (2016). Early report on brain arousal regulation in manic vs depressive episodes in bipolar disorder. Bipolar Disord, 18(6), 502-510.
     
  182. Schmidt R, Steinberg H (2016). [Müller-Hegemanns classification of depressions of 1964 as a proposal for a conceptualization of affective disorders: A critical review]. Fortschr Neurol Psychiatr, 84(6), 344-353.
     
  183. Schmidt FM, Kirkby KC, Lichtblau N (2016). Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. Review. Curr Neuropharmacol, 14(7), 674-687.
     
  184. Olbrich S, Tränkner A, Surova G, Gevirtz R, Gordon E, Hegerl U, Arns M (2016). CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study. J Psychiatr Res, 73, 108-115.
     
  185. Minkwitz J, Chittka T, Schuster S, Kirkby KC, Sander C, Hegerl U, Himmerich H (2016). Sensation seeking and physical activity. Health Behav Policy Rev, 3, 528-534.
     
  186. Hegerl U, Ulke C (2016). Fatigue with up- vs downregulated brain arousal should not be confused. Prog Brain Res, 229, 239-254.
     
  187. Kohls E, Dogan E, Hegerl U (2016). Ernährung und Depression: Die MooDFOOD Präventions-Studie. Public Health Forum, 24/3, 220-224.
     
  188. Kordy H, Wolf M, Aulich K, Bürgy M, Hegerl U, Husing J, Puschner B, Rummel-Kluge C, Vedder H, Backenstrass M (2016). Internet-Delivered Disease Management for Recurrent Depression: A Multicenter Randomized Controlled Trial. Psychother Psychosom, 85(2), 91-98.
     
  189. Arns M, Bruder G, Hegerl U, Spooner C, Palmer DM, Etkin A, Fallahpour K, Gatt JM, Hirshberg L, Gordon E (2016). EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study. Clin Neurophysiol, 127(1), 509-519.
     
  190. Buron P, Jimenez-Trevino L, Saiz PA, Garcia-Portilla MP, Corcoran P, Carli V, Fekete S, Hadlaczky G, Hegerl U, Michel K, Sarchiapone M, Temnik S, Varnick A, Verbanck P, Wasserman D, Schmidtke A, Bobes (2016). Reasons for Attempted Suicide in Europe: Prevalence, Associated Factors, and Risk of Repetition. Arch Suicide Res, 20(1), 45-58.
     
  191. Krause D, Folkerts M, Karch S, Keeser D, Chrobok AI, Zaudig M, Hegerl U, Juckel G, Pogarell O (2016). Prediction of Treatment Outcome in Patients with Obsessive-Compulsive Disorder with Low-Resolution Brain Electromagnetic Tomography: A Prospective EEG Study. Front Psychol, 6, 1993.
     
  192. Vittengl JR, Jarrett RB, Weitz E, Hollon SD, Twisk J, Cristea I, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Faramarzi M, Hegerl U, Kennedy SH, Kheirkhah F, Mergl R, Miranda J, Mohr DC, Rush AJ, Seg (2016). Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression. Am J Psychiatry, 173(5), 481-490.
     
  193. Roca M, Kohls E, Gili M, Watkins E, Owens M, Hegerl U, van Grootheest G, Bot M, Cabout M, Brouwer IA, Visser M, Penninx BW (2016). Prevention of depression through nutritional strategies in high-risk persons: rationale and design of the MooDFOOD prevention trial. BMC Psychiatry, 16, 192.
     
  194. Zalsman G, Hawton K, Wasserman D, van Heeringen K, Arensman E, Sarchiapone M, Carli V, Hoschl C, Barzilay R, Balazs J, Purebl G, Kahn JP, Saiz PA, Lipsicas CB, Bobes J, Cozman D, Hegerl U, Zohar J (2016). Suicide prevention strategies revisited: 10-year systematic review. Lancet Psychiatry, 3(7), 646-659.
     
  195. Klein JP, Gerlinger G, Knaevelsrud C, Bohus M, Meisenzahl E, Kersting A, Rohr S, Riedel-Heller SG, Sprick U, Dirmaier J, Harter M, Hegerl U, Hohagen F, Hauth I (2016). [Internet-based interventions in the treatment of mental disorders : Overview, quality criteria, perspectives]. Nervenarzt, 87(11), 1185-1193.
     
  196. Koppara A, Wolfsgruber S, Kleineidam L, Schmidtke K, Frolich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hull M, Gertz HJ, Schroder J, Pantel J, Rienhoff O, Ru (2016). The Latent Dementia Phenotype ? is Associated with Cerebrospinal Fluid Biomarkers of Alzheimers Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment. J Alzheimers Dis, 49(2), 547-560.
     
  197. Galluzzi S, Marizzoni M, Babiloni C, Albani D, Antelmi L, Bagnoli C, Bartres-Faz D, Cordone S, Didic M, Farotti L, Fiedler U, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo (2016). Clinical and biomarker profiling of prodromal Alzheimers disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a "European ADNI study". J Intern Med, 279(6), 576-591.
     
  198. Hegerl U, Sander C, Hensch T (2016). Arousal regulation in affective disorders. In: Frodl T, Systems Neuroscience in Depression. (S. 341-370), London: Elsevier.
     
  199. Hegerl U (2016). Vom Nürnberger Bündnis gegen Depression zur European Alliance Against Depression. In: Glasow N, Hery D, Das nationale Suizidpräventionsprogramm für Deutschland. (S. 147-151), Regensburg: Roderer.
     


  200. 2015


  201. Petersein C, Sack U, Mergl R, Schönherr J, Schmidt FM, Lichtblau N, Kirkby KC, Bauer K, Himmerich H (2015). Impact of lithium alone and in combination with antidepressants on cytokine production in vitro. J Neural Transm, 122(1), 109-122.
     
  202. Schmidt FM, Nowak C, Kratzsch J, Sander C, Hegerl U, Schönknecht P (2015). Dynamics of melanin-concentrating hormone (MCH) serum levels in major depressive disorder during antidepressant treatment. J Affect Disord, 180, 207-213.
     
  203. Schmidt FM, Weschenfelder J, Sander C, Minkwitz J, Thormann J, Chittka T, Mergl R, Kirkby KC, Fasshauer M, Stumvoll M, Holdt LM, Teupser D, Hegerl U, Himmerich H (2015). Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One, 10(3), e0121971.
     
  204. Strauß M, Mergl R, Sander C, Schönknecht P, Bock K, Hegerl U (2015). "Onset of Depression Inventory"-comparison between the data of depressed patients and their relatives. Int J Psychiatry Clin Pract, 19(3), 188-191.
     
  205. Olbrich S, Fischer MM, Sander C, Hegerl U, Wirtz H, Bosse-Henck A (2015). Objective markers for sleep propensity: comparison between the Multiple Sleep Latency Test and the Vigilance Algorithm Leipzig. J Sleep Res, 24(4), 450-457.
     
  206. Hensch T, Blume A, Böttger D, Sander C, Niedermeier N, Hegerl U (2015). Yawning in depression: worth looking into. Pharmacopsychiatry, 48(3), 118-120.
     
  207. Strauß M, Mergl R, Sander C, Schönknecht P, Hegerl U (2015). Association of speed of onset and speed of recovery of depressive episodes in patients with major depression. Psychopathology, 48(1), 65-68.
     
  208. Schmidt FM, Steinberg H, Himmerich H (2015). [Differential diagnosis of bipolar disorder: historical and clinical implications and perspectives]. Fortschr Neurol Psychiatr, 83(2), 74-82.
     
  209. Schmidt FM, Mergl R, Stach B, Jahn I, Schonknecht P (2015). Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder. World J Biol Psychiatry, 16(2), 106-113.
     
  210. Trefflich F, Kalckreuth S, Mergl R, Rummel-Kluge C (2015). Psychiatric patients internet use corresponds to the internet use of the general public. Psychiatry Res, 226(1), 136-141.
     
  211. Arensman E, Koburger N, Larkin C, Karwig G, Coffey C, Maxwell M, Harris F, Rummel-Kluge C, van Audenhove C, Sisask M, Alexandrova-Karamanova A, Perez V, Purebl G, Cebria A, Palao D, Costa S, Mark L, Toth MD, Gecheva M, Ibelshauser A, Gusmao R, Hegerl U (2015). Depression Awareness and Self-Management Through the Internet: Protocol for an Internationally Standardized Approach. JMIR Res Protoc, 4(3), e99.
     
  212. Jawinski P, Sander C, Mauche N, Spada J, Huang J, Schmidt A, Hantzsch M, Burkhardt R, Scholz M, Hegerl U, Hensch T (2015). Brain Arousal Regulation in Carriers of Bipolar Disorder Risk Alleles. Neuropsychobiology, 72(2), 65-73.
     
  213. Cuijpers P, Karyotaki E, Andersson G, Li J, Mergl R, Hegerl U (2015). The effects of blinding on the outcomes of psychotherapy and pharmacotherapy for adult depression: A meta-analysis. Eur Psychiatry, 30(6), 685-693.
     
  214. Strauß M, Mergl R, Schindler S, Sander C, Schönknecht P, Hegerl U (2015). What Does the Speed of Onset of a Depressive Episode Tell Us? J Psychiatr Pract, 21(4), 275-280.
     
  215. Mergl R, Koburger N, Heinrichs K, Szekely A, Toth MD, Coyne J, Quintao S, Arensman E, Coffey C, Maxwell M, Varnik A, van Audenhove C, McDaid D, Sarchiapone M, Schmidtke A, Genz A, Gusmao R, Hegerl U (2015). What Are Reasons for the Large Gender Differences in the Lethality of Suicidal Acts? An Epidemiological Analysis in Four European Countries. PLoS One, 10(7), e0129062.
     
  216. Koburger N, Mergl R, Rummel-Kluge C, Ibelshauser A, Meise U, Postuvan V, Roskar S, Szekely A, Ditta Toth M, van der Feltz-Cornelis C, Hegerl U (2015). Celebrity suicide on the railway network: Can one case trigger international effects? J Affect Disord, 185, 38-46.
     
  217. Hegerl U, Koburger N, Hug J (2015). Depression und Suizidalität Nervenheilkunde, 34(11), 900-905.
     
  218. Polyakova M, Sander C, Arelin K, Lampe L, Luck T, Luppa M, Kratzsch J, Hoffmann KT, Riedel-Heller S, Villringer A, Schönknecht P, Schröter ML (2015). First evidence for glial pathology in late life minor depression: S100B is increased in males with minor depression. Front Cell Neurosci, 9, 406.
     
  219. Sander C, Hensch T, Wittekind DA, Böttger D, Hegerl U (2015). Assessment of Wakefulness and Brain Arousal Regulation in Psychiatric Research. Neuropsychobiology, 72(3-4), 195-205.
     
  220. Forsman AK, Wahlbeck K, Aaro LE, Alonso J, Barry MM, Brunn M, Cardoso G, Cattan M, de Girolamo G, Eberhard-Gran M, Evans-Lacko S, Fiorillo A, Hansson L, Haro JM, Hazo JB, Hegerl U, Katschnig H, Knappe (2015). Research priorities for public mental health in Europe: recommendations of the ROAMER project. Eur J Public Health, 25(2), 249-254.
     
  221. Arns M, Etkin A, Hegerl U, Williams LM, DeBattista C, Palmer DM, Fitzgerald PB, Harris A, deBeuss R, Gordon E (2015). Frontal and rostral anterior cingulate (rACC) theta EEG in depression: Implications for treatment outcome? Eur Neuropsychopharmacol, 25(8), 1190-1200.
     
  222. Wolfsgruber S, Jessen F, Koppara A, Kleineidam L, Schmidtke K, Frolich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hull M, Gertz HJ, Schroder J, Pantel J, Rien (2015). Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI. Neurology, 84(12), 1261-1268.
     
  223. Cebria AI, Perez-Bonaventura I, Cuijpers P, Kerkhof A, Parra I, Escayola A, Garcia-Pares G, Oliva JC, Punti J, Lopez D, Valles V, Pamias M, Hegerl U, Perez-Sola V, Palao DJ (2015). Telephone Management Program for Patients Discharged From an Emergency Department After a Suicide Attempt. Crisis, 36(5), 345-352.
     
  224. Weitz ES, Hollon SD, Twisk J, van Straten A, Huibers MJ, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Cristea IA, Faramarzi M, Hegerl U, Jarrett RB, Kheirkhah F, Kennedy SH, Mergl R, Miranda J, Mohr (2015). Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis. JAMA Psychiatry, 72(11), 1102-1109.
     
  225. Löffler M, Engel C, Ahnert P, Alfermann D, Arelin K, Baber R, Beutner F, Binder H, Brahler E, Burkhardt R, Ceglarek U, Enzenbach C, Fuchs M, Gläsmer H, Girlich F, Hagendorff A, Hantzsch M, Hegerl U, H (2015). The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany. BMC Public Health, 15, 691.
     
  226. Koppara A, Wolfsgruber S, Kleineidam L, Schmidtke K, Frolich L, Kurz A, Schulz S, Hampel H, Heuser I, Peters O, Reischies FM, Jahn H, Luckhaus C, Hull M, Gertz HJ, Schroder J, Pantel J, Rienhoff O, Ru (2015). The Latent Dementia Phenotype ? is Associated with Cerebrospinal Fluid Biomarkers of Alzheimers Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment. J Alzheimers Dis, 49(2), 547-560.
     
  227. Loeffler M, Engel C, Ahnert P, Alfermann D, Arelin K, Baber R, Beutner F, Binder H, Brahler E, Burkhardt R, Ceglarek U, Enzenbach C, Fuchs M, Glaesmer H, Girlich F, Hagendorff A, Hantzsch M, Hegerl U, (2015). The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany. BMC Public Health, 15, 691.
     


  228. 2014


  229. Hegerl U, Hensch T (2014). The vigilance regulation model of affective disorders and ADHD. Neurosci Biobehav Rev, 44C, 45-57.
     
  230. Strauss M, Mergl R, Sander C, Doehring C, Schönknecht P, Angst J, Hegerl U (2014). Test-Retest Stability of the Onset of Depression Inventory. Psychopathology, 47(1), 45-50.
     
  231. Geissler J, Romanos M, Hegerl U, Hensch T (2014). Hyperactivity and sensation seeking as autoregulatory attempts to stabilize brain arousal in ADHD and mania? Atten Defic Hyperact Disord, 6(3), 159-73.
     
  232. Strauss M, Mergl R, Kratzsch J, Brugel M, Strauss E, Hegerl U, Schoenknecht P (2014). Differentiation between free and bound leptin in depressed patients. Psychiatry Res, 219(2), 397-399.
     
  233. Steinberg H, Hegerl U (2014). Johann Christian August Heinroth on sleep deprivation as a therapeutic option for depressive disorders. Sleep Med, 15(9), 1159-64.
     
  234. Spada J, Sander C, Burkhardt R, Hantzsch M, Mergl R, Scholz M, Hegerl U, Hensch T (2014). Genetic association of objective sleep phenotypes with a functional polymorphism in the neuropeptide s receptor gene. PLoS One, 9(6), e98789.
     
  235. Coppens E, Van Audenhove C, Iddi S, Arensman E, Gottlebe K, Koburger N, Coffey C, Gusmao R, Quintao S, Costa S, Szekely A, Hegerl U (2014). Effectiveness of community facilitator training in improving knowledge, attitudes, and confidence in relation to depression and suicidal behavior: results of the OSPI-Europe intervention in four European countries. J Affect Disord, 165, 142-150.
     
  236. Hegerl U, Mergl R (2014). Depression and suicidality in COPD: understandable reaction or independent disorders? Eur Respir J, 44(3), 734-743.
     
  237. Schmidt FM, Lichtblau N, Minkwitz J, Chittka T, Thormann J, Kirkby KC, Sander C, Mergl R, Fasshauer M, Stumvoll M, Holdt LM, Teupser D, Hegerl U, Himmerich H (2014). Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J Psychiatr Res, 55, 29-34.
     
  238. Adli M, Hegerl U (2014). Do we underestimate the benefits of antidepressants? Lancet, 383(9926), 1361-1362.
     
  239. Olbrich S, Trankner A, Chittka T, Hegerl U, Schonknecht P (2014). Functional connectivity in major depression: increased phase synchronization between frontal cortical EEG-source estimates. Psychiatry Res, 222(1-2), 91-99.
     
  240. Himmerich H, Bartsch S, Hamer H, Mergl R, Schonherr J, Petersein C, Munzer A, Kirkby KC, Bauer K, Sack U (2014). Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro. Oxid Med Cell Longev, 2014, 806162.
     
  241. Polyakova M, Sonnabend N, Sander C, Mergl R, Schroeter ML, Schroeder J, Schonknecht P (2014). Prevalence of minor depression in elderly persons with and without mild cognitive impairment: a systematic review. J Affect Disord, 152-154, 28-38.
     
  242. Schmidt FM, Mergl R, Stach B, Jahn I, Gertz HJ, Schonknecht P (2014). Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimers disease. Neurosci Lett, 570, 81-85.
     
  243. Himmerich H, Kohls E, Hegerl U, Rummel-Kluge C (2014). [Predictive factors of depression and its therapy]. Nervenarzt, 85(10), 1249-1254.
     
  244. Schmidt FM, Kirkby KC, Himmerich H (2014). The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases. Psychiatr Danub, 26(3), 288-290.
     
  245. Tittmann M, Günther T, Sacher J, Himmerich H, Villringer A, Hegerl U, Schönknecht P (2014). Structural brain changes in early-onset and late-onset depression: An update of volumetric MRI findings. International Journal of Imaging Systems and Technology, 24(2), 149-160.
     
  246. Hegerl U (2014). Largely unnoticed flaws in the fundamentals of depression diagnosis: The semantics of core symptoms. Aust N Z J Psychiatry, 48(12), 1166.
     
  247. Dietrich S, Mergl R, Rummel-Kluge C (2014). Personal and perceived stigmatization of depression: A comparison of data from the general population, participants of a depression congress and job placement officers in Germany. Psychiatry Res, 220(1-2), 598-603.
     
  248. Maloney J, Pfuhlmann B, Arensman E, Coffey C, Gusmao R, Postuvan V, Scheerder G, Sisask M, van der Feltz-Cornelis CM, Hegerl U, Schmidtke A (2014). How to adjust media recommendations on reporting suicidal behavior to new media developments. Arch Suicide Res, 18(2), 156-169.
     
  249. Bekhtereva V, Sander C, Forschack N, Olbrich S, Hegerl U, Muller MM (2014). Effects of EEG-vigilance regulation patterns on early perceptual processes in human visual cortex. Clin Neurophysiol, 125(1), 98-107.
     
  250. Carli V, Mandelli L, Zaninotto L, Iosue M, Hadlaczky G, Wasserman D, Hegerl U, Varnik A, Reisch T, Pfuhlmann B, Maloney J, Schmidtke A, Serretti A, Sarchiapone M (2014). Serious suicidal behaviors: socio-demographic and clinical features in a multinational, multicenter sample. Nord J Psychiatry, 68(1), 44-52.
     
  251. Cuijpers P, Weitz E, Twisk J, Kuehner C, Cristea I, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Faramarzi M, Hegerl U, Jarrett RB, Kennedy SH, Kheirkhah F, Mergl R, Miranda J, Mohr DC, Segal ZV, Sid (2014). Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis. Depress Anxiety, 31(11), 941-951.
     
  252. Liwowsky I, Mergl R, Padberg F (2014). SBT-Depressionstherapie in und mit der Gruppe ? Konzeption und Evaluation im stationär-psychiatrischen Setting Psychotherapie in Psychiatrie, Psychotherapeutischer Medizin und klinischer Psychologie, 19, 106-121.
     
  253. Hegerl U, Mergl R (2014). Unipolare Depression. In: Juckel G, Edel MA, Neurologie und Psychotherapie. (S. 90-103), Stuttgart: Schattauer.
     
  254. Pogarell O, Hegerl U (2014). Ereigniskorrelierte Potenziale in der Psychiatrie. In: Buchner H, Praxisbuch Evozierte Potenziale: Grundlagen, Befundung, Beurteilung und differenzialdiagnostische Abgrenzung. (S. 147-152), Stuttgart: Thieme.
     


  255. 2013


  256. Hegerl U, Mergl R, Quail D, Schneider E, Strauss M, Hundemer HP, Linden M (2013). Fast versus slow onset of depressive episodes: A clinical criterion for subtyping patients with major depression. Eur Psychiatry, 28(5), 288-92.
     
  257. Hegerl U, Koburger N, Rummel-Kluge C, Gravert C, Walden M, Mergl R (2013). One followed by many?-Long-term effects of a celebrity suicide on the number of suicidal acts on the German railway net. J Affect Disord, 146(1), 39-44.
     
  258. Schmidt FM, Lichtblau N, Uribe MM, Kirchherr H, Himmerich H (2013). Agomelatine in breast milk. Int J Neuropsychopharmacol, 16(2), 497-499.
     
  259. Schmidt FM, Schonherr J, Sander C, Kirkby KC, Hegerl U, Himmerich H (2013). Applying EEG-based vigilance measurement in a case of adult attention deficit hyperactivity disorder. Int J Neuropsychopharmacol, 16(5), 1169-71.
     
  260. Gertz HJ, Stoppe G, Muller-Oerlinghausen B, Schmidt LG, Baethge C, Hiemke C, Lieb K, Bschor T (2013). [Antipsychotics for treatment of neuropsychiatric disorders in dementia.] Nervenarzt, 84(3), 370-3.
     
  261. Olbrich S, Olbrich H, Jahn I, Sander C, Adamaszek M, Hegerl U, Reque F, Stengler K (2013). EEG-vigilance regulation during the resting state in obsessive-compulsive disorder. Clin Neurophysiol, 124(3), 497-502.
     
  262. Hegerl U, Lam RW, Malhi GS, McIntyre RS, Demyttenaere K, Mergl R, Gorwood P (2013). Conceptualising the neurobiology of fatigue. Aust N Z J Psychiatry, 47(4), 312-316.
     
  263. Kluge M, Hegerl U, Sander C, Dietzel J, Mergl R, Bitter I, Demyttenaere K, Gusmao R, Gonzalez-Pinto A, Perez-Sola V, Vieta E, Juckel G, Zimmermann US, Bauer M, Sienaert P, Quintao S, Edel MA, Bolyos C, Ayuso-Mateos JL, Lopez-Garcia P (2013). Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate. BMC Psychiatry, 13, 71.
     
  264. Lopez-Garcia P, Hegerl U (2013). Treatment of acute mania with methylphenidate: therapeutic approach based on a new pathophysiological model. Rev Psiquiatr Salud Ment, 6(2), 93-94.
     
  265. Schmidt FM, Kratzsch J, Gertz HJ, Tittmann M, Jahn I, Pietsch UC, Kaisers UX, Thiery J, Hegerl U, Schönknecht P (2013). Correction: Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer's Disease. PLoS One, 8(6), e63136.
     
  266. Schindler S, Schönknecht P, Schmidt L, Anwander A, Strauss M, Trampel R, Bazin PL, Moller HE, Hegerl U, Turner R, Geyer S (2013). Development and evaluation of an algorithm for the computer-assisted segmentation of the human hypothalamus on 7-tesla magnetic resonance images. PLoS One, 8(7), e66394.
     
  267. Hegerl U (2013). [Should treatment of mild depression be exclusively psychotherapeutic? Against]. Nervenarzt, 84(3), 388-389.
     
  268. Schönknecht P, Anwander A, Petzold F, Schindler S, Knosche TR, Moller HE, Hegerl U, Turner R, Geyer S (2013). Diffusion imaging-based subdivision of the human hypothalamus: a magnetic resonance study with clinical implications. Eur Arch Psychiatry Clin Neurosci, 263(6), 497-508.
     
  269. Bühler B, Kocalevent R, Berger R, Mahler A, Preiss B, Liwowsky I, Carl P, Hegerl U (2013). [Treatment situation of long-term unemployed with psychological disorders]. Nervenarzt, 84(5), 603-607.
     
  270. Szekely A, Konkoly Thege B, Mergl R, Birkas E, Rozsa S, Purebl G, Hegerl U (2013). How to Decrease Suicide Rates in Both Genders? An Effectiveness Study of a Community-Based Intervention (EAAD). PLoS One, 8(9), e75081.
     
  271. Harris FM, Maxwell M, O'Connor RC, Coyne J, Arensman E, Szekely A, Gusmao R, Coffey C, Costa S, Cserhati Z, Koburger N, van Audenhove C, McDaid D, Maloney J, Varnik P, Hegerl U (2013). Developing social capital in implementing a complex intervention: a process evaluation of the early implementation of a suicide prevention intervention in four European countries. BMC Public Health, 13, 158.
     
  272. Hegerl U, Mergl R, Doganay G, Reschke K, Rummel-Kluge C (2013). Why has the continuous decline in german suicide rates stopped in 2007? PLoS One, 8(8), e71589.
     
  273. Jödicke J, Olbrich S, Sander C, Minkwitz J, Chittka T, Himmerich H, Hegerl U (2013). Separation of low-voltage EEG-activity during mental activation from that during transition to drowsiness. Brain Topogr, 26(4), 538-546.
     
  274. Allgaier AK, Kramer D, Saravo B, Mergl R, Fejtkova S, Hegerl U (2013). Beside the Geriatric Depression Scale: the WHO-Five Well-being Index as a valid screening tool for depression in nursing homes. Int J Geriatr Psychiatry, 28(11), 1197-1204.
     
  275. Lam RW, Malhi GS, McIntyre RS, Demyttenaere K, Gorwood P, Michalak EE, Hegerl U (2013). Fatigue and occupational functioning in major depressive disorder. Aust N Z J Psychiatry, 47(11), 989-991.
     
  276. Hegerl U, Rummel-Kluge C, Varnik A, Arensman E, Koburger N (2013). Alliances against depression - A community based approach to target depression and to prevent suicidal behaviour. Neurosci Biobehav Rev, 37(10 Pt 1), 2404-9.
     
  277. Olbrich S, Olbrich H, Adamaszek M, Jahn I, Hegerl U, Stengler K (2013). Altered EEG lagged coherence during rest in obsessive-compulsive disorder. Clin Neurophysiol, 124(12), 2421-2430.
     
  278. Coppens E, Van Audenhove C, Scheerder G, Arensman E, Coffey C, Costa S, Koburger N, Gottlebe K, Gusmao R, O\'Connor R, Postuvan V, Sarchiapone M, Sisask M, Szekely A, van der Feltz-Cornelis C, Hegerl U (2013). Public attitudes toward depression and help-seeking in four European countries baseline survey prior to the OSPI-Europe intervention. J Affect Disord, 150(2), 320-329.
     
  279. Strauss M, Mergl R, Sander C, Doehring C, Schönknecht P, Angst J, Hegerl U (2013). Test-retest stability of the onset of depression inventory. Psychopathology, 47(1), 45-50.
     
  280. Tränkner A, Sander C, Schönknecht P (2013). A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder. Neuropsychiatr Dis Treat, 9, 101-111.
     
  281. Kluge M, Schmidt D, Uhr M, Steiger A (2013). Ghrelin suppresses nocturnal secretion of luteinizing hormone (LH) and thyroid stimulating hormone (TSH) in patients with major depression. J Psychiatr Res, 47(9), 1236-1239.
     
  282. Pfeil S, Holtz K, Tiefensee J, Bresner T, Kästner A, Kopf A, Hegerl U (2013). Hilfe für psychisch kranke Langzeitarbeitslose. Nervenheilkunde, 32(8), 592-594.
     
  283. Hegerl U, Friede M (2013). Psychische Erkrankungen in Deutschland. Optimierungsspielpläne und Handlungsbedarf. Nervenheilkunde, 32(10), 762-765.
     
  284. Lichtblau N, Schmidt FM, Schumann R, Kirkby KC, Himmerich H (2013). Cytokines as biomarkers in depressive disorder: current standing and prospects. Int Rev Psychiatry, 25(5), 592-603.
     
  285. Munzer A, Sack U, Mergl R, Schönherr J, Petersein C, Bartsch S, Kirkby KC, Bauer K, Himmerich H (2013). Impact of antidepressants on cytokine production of depressed patients in vitro. Toxins (Basel), 5(11), 2227-2240.
     
  286. Himmerich H, Bartsch S, Hamer H, Mergl R, Schönherr J, Petersein C, Munzer A, Kirkby KC, Bauer K, Sack U (2013). Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro. J Psychiatr Res, 47(11), 1751-1759.
     
  287. Schmidt L, Ceglarek U, Kortz L, Hoop M, Kirkby KC, Thiery J, Himmerich H (2013). Mechanisms of Involvement of Eicosanoids and their Precursors in the Pathophysiology and Treatment of Schizophrenia. Med Chem, 9(6), 763-773.
     
  288. Rhein C, Naumann J, Muhle C, Zill P, Adli M, Hegerl U, Hiemke C, Mergl R, Moller HJ, Reichel M, Kornhuber J (2013). The Acid Sphingomyelinase Sequence Variant p.A487V Is Not Associated With Decreased Levels of Enzymatic Activity. JIMD Rep, 8, 1-6.
     
  289. Cebria AI, Parra I, Pamias M, Escayola A, Garcia-Pares G, Punti J, Laredo A, Valles V, Cavero M, Oliva JC, Hegerl U, Perez-Sola V, Palao DJ (2013). Effectiveness of a telephone management programme for patients discharged from an emergency department after a suicide attempt: controlled study in a Spanish population. J Affect Disord, 147(1-3), 269-276.
     
  290. Andreou C, Leicht G, Popescu V, Pogarell O, Mavrogiorgou P, Rujescu D, Giegling I, Zaudig M, Juckel G, Hegerl U, Mulert C (2013). P300 in obsessive-compulsive disorder: Source localization and the effects of treatment. J Psychiatr Res, 47(12), 1975-1983.
     
  291. Anderson-Schmidt H, Adler L, Aly C, Anghelescu IG, Bauer M, Baumgartner J, Becker J, Bianco R, Becker T, Bitter C, Bonsch D, Buckow K, Budde M, Buhrig M, Deckert J, Demiroglu SY, Dietrich D, Dumpelman (2013). The "DGPPN-Cohort": a national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients. Eur Arch Psychiatry Clin Neurosci, 263(8), 695-701.
     
  292. Jovicich J, Marizzoni M, Sala-Llonch R, Bosch B, Bartres-Faz D, Arnold J, Benninghoff J, Wiltfang J, Roccatagliata L, Nobili F, Hensch T, Tränkner A, Schönknecht P, Leroy M, Lopes R, Bordet R, Chanoin (2013). Brain morphometry reproducibility in multi-center 3T MRI studies: A comparison of cross-sectional and longitudinal segmentations. Neuroimage, 83, 472-484.
     


  293. 2012


  294. Cibis A, Mergl R, Bramesfeld A, Althaus D, Niklewski G, Schmidtke A, Hegerl U (2012). Preference of lethal methods is not the only cause for higher suicide rates in males. J Affect Disord, 136(1-2), 9-16.
     
  295. Boenisch S, Kocalevent RD, Matschinger H, Mergl R, Wimmer-Brunauer C, Tauscher M, Kramer D, Hegerl U, Bramesfeld A (2012). Who receives depression-specific treatment? A secondary data-based analysis of outpatient care received by over 780,000 statutory health-insured individuals diagnosed with depression. Soc Psychiatry Psychiatr Epidemiol, 47(3), 475-86.
     
  296. Hegerl U, Wilk K, Olbrich S, Schönknecht P, Sander C (2012). Hyperstable regulation of vigilance in patients with major depressive disorder. World J Biol Psychiatry, 13(6), 436-46.
     
  297. Hegerl U, Allgaier AK, Henkel V, Mergl R (2012). Can effects of antidepressants in patients with mild depression be considered as clinically significant? J Affect Disord, 138(3), 183-91.
     
  298. Dietrich S, Deckert S, Ceynowa M, Hegerl U, Stengler K (2012). Depression in the workplace: a systematic review of evidence-based prevention strategies. Int Arch Occup Environ Health, 85(1), 1-11.
     
  299. Hegerl U, Mergl R, Quail D, Schneider E, Hundemer HP, Linden M (2012). Does Pain Improve Earlier than Mood in Depressed Patients with Painful Physical Symptoms Treated with Duloxetine? Pharmacopsychiatry, 45(3), 114-8.
     
  300. Värnik P, Sisask M, Värnik A, Arensman E, Van Audenhove C, van der Feltz-Cornelis CM, Hegerl U (2012). Validity of suicide statistics in Europe in relation to undetermined deaths: developing the 2-20 benchmark. Inj Prev, 18(5), 321-5.
     
  301. Schindler S, Geyer S, Strauss M, Anwander A, Hegerl U, Turner R, Schönknecht P (2012). Structural studies of the hypothalamus and its nuclei in mood disorders. Psychiatry Res, 201(1), 1-9.
     
  302. Olbrich S, Sander C, Jahn I, Eplinius F, Claus S, Mergl R, Schönknecht P, Hegerl U (2012). Unstable EEG-vigilance in patients with cancer-related fatigue (CRF) in comparison to healthy controls. World J Biol Psychiatry, 13(2), 146-152.
     
  303. Hegerl U, Schönknecht P, Mergl R (2012). Are antidepressants useful in the treatment of minor depression: a critical update of the current literature. Curr Opin Psychiatry, 25(1), 1-6.
     
  304. Hegerl U (2012). Review: risperidone, olanzapine and haloperidol are the most effective drugs for acute mania in adults with bipolar I disorder. Commentary. Evid Based Ment Health, 15(2), 45.
     
  305. Olbrich S, Sander C, Minkwitz J, Chittka T, Mergl R, Hegerl U, Himmerich H (2012). EEG Vigilance Regulation Patterns and Their Discriminative Power to Separate Patients with Major Depression from Healthy Controls. Neuropsychobiology, 65(4), 188-194.
     
  306. Hegerl U, Holtzheimer P, Mergl R, McDonald W (2012). The neurobiology and treatment of late-life depression. Handb Clin Neurol, 106, 265-278.
     
  307. Schonknecht P, Hegerl U (2012). [Dysthymia]. Fortschr Neurol Psychiatr, 80(10), 602-608.
     
  308. Strauss M, Sander C, Mergl R, Merz C, Schonknecht P, Hegerl U (2012). Onset of Depression Inventory (ODI)-Assessment of the speed of onset of depressive episodes. J Affect Disord, 142(1-3), 156-160.
     
  309. Dietrich S, Mergl R, Rummel-Kluge C, Stengler K (2012). [Mental health in the working world from the perspective of occupational physicians]. Psychiatr Prax, 39(1), 40-42.
     
  310. Weschenfelder J, Sander C, Kluge M, Kirkby KC, Himmerich H (2012). The influence of cytokines on wakefulness regulation: clinical relevance, mechanisms and methodological problems. Psychiatr Danub, 24(2), 112-126.
     
  311. Schmidt FM, Tennert C, Teupser D, Himmerich H (2012). [Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression]. Psychiatr Prax, 39(5), 239-242.
     
  312. Himmerich H, Schmidt L, Becker S, Kortz L, Schonherr J, Mergl R, Bauer K, Sack U, Sheldrick AJ, Thiery J, Ceglarek U (2012). Impact of clozapine, N-desmethylclozapine and chlorpromazine on thromboxane production in vitro. Med Chem, 8(6), 1032-1038.
     
  313. Minkwitz J, Trenner MU, Sander C, Olbrich S, Sheldrick AJ, Hegerl U, Himmerich H (2012). Time perception at different EEG-vigilance levels. Behav Brain Funct, 8, 50.
     
  314. Lichtblau N, Schmidt FM, Himmerich H (2012). Immunsystem und Depression. Die Rolle von Zytokinen bei der Depression. InFo Neurologie & Psychiatrie, 9, 60-68.
     
  315. Koburger N, Rummel-Kluge C, Mergl R, Cibis A, Hegerl U (2012). Mehr Suizidversuche bei Frauen, höhere Letalität bei Männern. Neurotransmitter, 23, 40-42.
     
  316. Hegerl U, Mergl R (2012). Randomisierte klinische Studien zur Wirkung von Antidepressiva - Die Wirksamkeit bei weniger schweren depressiven Störungen wird unterschätzt. InFo Neurologie & Psychiatrie, 14, 8-9.
     
  317. Kluge M, Schussler P, Schmidt D, Uhr M, Steiger A (2012). Ghrelin suppresses secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in women. J Clin Endocrinol Metab, 97(3), E448-451.
     
  318. Hegerl U, Heussner P, Hiddemann W (2012). Psychische Störungen in der inneren Medizin. Internist, 53(11), 1269-1270.
     
  319. Helmreich I, Wagner S, Mergl R, Allgaier AK, Hautzinger M, Henkel V, Hegerl U, Tadic A (2012). Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression. Eur Arch Psychiatry Clin Neurosci, 262(4), 291-304.
     
  320. Juckel G, Karch S, Kawohl W, Kirsch V, Jäger L, Leicht G, Lutz J, Stammel A, Pogarell O, Ertl M, Reiser M, Hegerl U, Möller HJ, Mulert C (2012). Age effects on the P300 potential and the corresponding fMRI BOLD-signal. Neuroimage, 60(4), 2027-2034.
     
  321. Heredia Montesinos A, Rapp MA, Temur-Erman S, Heinz A, Hegerl U, Schouler-Ocak M (2012). The influence of stigma on depression, overall psychological distress, and somatization among female Turkish migrants. Eur Psychiatry, 27, S22-26.
     
  322. Wilhelm S, Boess FG, Hegerl U, Mergl R, Linden M, Schacht A, Schneider E (2012). Tolerability aspects in duloxetine-treated patients with depression: should one use a lower starting dose in clinical practice? Expert Opin Drug Saf, 11(5), 699-711.
     
  323. Schaaff N, Karch S, Segmiller F, Koch W, Reicherzer M, Mulert C, Hegerl U, Juckel G, Pogarell O (2012). Loudness dependence of auditory evoked potentials in patients with borderline personality disorder-Impact of psychopathology. Psychiatry Res, 199(3), 181-7.
     
  324. Peters O, Lorenz D, Fesche A, Schmidtke K, Hull M, Perneczky R, Ruther E, Moller HJ, Jessen F, Maier W, Kornhuber J, Jahn H, Luckhaus C, Gertz HJ, Schroder J, Pantel J, Teipel S, Wellek S, Frolich L, (2012). A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. J Nutr Health Aging, 16(6), 544-548.
     
  325. Kern N, Sheldrick AJ, Schmidt FM, Minkwitz J (2012). Neurobiology of depression and novel antidepressant drug targets. Curr Pharm Des, 18(36), 5791-5801.
     
  326. Kocalevent RD, Holtz K, Schützwohl M, Müller AG, Bramesfeld A, Hegerl U, Bönisch-Alert S (2012). Bedarfsanalyse für Kinder psychisch kranker Eltern in Nervenarztpraxen. Nervenheilkunde, 31(4), 272-277.
     
  327. Hegerl U, Holtzheimer P, Mergl R, McDonald W (2012). The neurobiology and tretatment of late-life depression. In: Schläpfer TE, Nemeroff CB, Neurobiology of Psychiatric Disorders (Handbook of Clinical Neurology). (S. 265-278), Edingburgh: Elsevier.
     
  328. Pogarell O, Hensch T, Hegerl U (2012). Elektroenzephalographie in der Psychopharmakotherapie. In: Gründer G, Benkert O, Handbuch der psychiatrischen Pharmakotherapie. (S. 399-416), Heidelberg: Spinger.
     


  329. 2011


  330. Hensch T, Himmerich H, Hegerl U (2011). ADHD and Bipolar Disorder: Common Causes Common Cure? J Atten Disord, 15(2), 99-100.
     
  331. Scheerder G, Van Audenhove C, Arensman E, Bernik B, Giupponi G, Horel AC, Maxwell M, Sisask M, Szekely A, Varnik A, Hegerl U (2011). Community and health professionals' attitude toward depression: A pilot study in nine EADD countries. Int J Soc Psychiatry, 57(4), 387-401.
     
  332. Olbrich S, Jodicke J, Sander C, Himmerich H, Hegerl U (2011). ICA-based muscle artefact correction of EEG data: what is muscle and what is brain? Comment on McMenamin et al. Neuroimage, 54(1), 1-3.
     
  333. Mergl R, Henkel V, Allgaier AK, Kramer D, Hautzinger M, Kohnen R, Coyne J, Hegerl U (2011). Are Treatment Preferences Relevant in Response to Serotonergic Antidepressants and Cognitive-Behavioral Therapy in Depressed Primary Care Patients? Results from a Randomized Controlled Trial Including a Patients' Choice Arm. Psychother Psychosom, 80(1), 39-47.
     
  334. Graef S, Schonknecht P, Sabri O, Hegerl U (2011). Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings. Psychopharmacology, 215(2), 205-229.
     
  335. Värnik A, Sisask M, Varnik P, Wu J, Kolves K, Arensman E, Maxwell M, Reisch T, Gusmao R, van Audenhove C, Scheerder G, van der Feltz-Cornelis CM, Coffey C, Kopp M, Szekely A, Roskar S, Hegerl U (2011). Drug suicide: a sex-equal cause of death in 16 European countries. BMC Public Health, 11(1), e61.
     
  336. Guenther T, Schönknecht P, Becker G, Olbrich S, Sander C, Hesse S, Meyer PM, Luthardt J, Hegerl U, Sabri O (2011). Impact of EEG-vigilance on brain glucose uptake measured with [(18)F]FDG and PET in patients with depressive episode or mild cognitive impairment. Neuroimage, 56(1), 93-101.
     
  337. Liwowsky I, Mergl R, Allgaier AK, Hegerl U (2011). [Prevalence of mental disorders in the elderly long-term unemployed. Comparison of results of the project KompAQT and the German National Health Interview and Examination Survey]. Neuropsychiatr, 25(1), 36-43.
     
  338. Hegerl U (2011). [Pro and con: Antidepressants also for mild depression?] MMW Fortschr Med, 153(29-31), 30.
     
  339. Schneider E, Linden M, Weigmann H, Wagner T, Quail D, Hundemer HP, Hegerl U (2011). Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine. BMC Psychiatry, 11, e150.
     
  340. Minkwitz J, Trenner MU, Sander C, Olbrich S, Sheldrick AJ, Schönknecht P, Hegerl U, Himmerich H (2011). Prestimulus vigilance predicts response speed in an easy visual discrimination task. Behav Brain Funct, 7, e31.
     
  341. Allgaier AK, Kramer D, Mergl R, Fejtkova S, Hegerl U (2011). [Validity of the geriatric depression scale in nursing home residents: comparison of GDS-15, GDS-8 and GDS-4] Psychiatr Prax, 38(6), 280-286.
     
  342. Hegerl U, Mergl R (2011). Kommentar zu Antidepressivatherapie bei Erwachsenen. Gibt es Unterschiede beim Suizidrisiko. INFO Neurologie & Psychiatrie, 13(3), 22.
     
  343. Adamaszek M, Olbrich S, Hegerl U, Schönknecht P (2011). [The risk for myocarditis of clozapine and other atypical antipsychotics: case report and study of the literature]. Psychiatr Prax, 38(4), 201-203.
     
  344. Kluge M, Schussler P, Dresler M, Schmidt D, Yassouridis A, Uhr M, Steiger A (2011). Effects of ghrelin on psychopathology, sleep and secretion of cortisol and growth hormone in patients with major depression. J Psychiatr Res, 45(3), 421-426.
     
  345. Mergl R, Havers I, Althaus D, Rihmer Z, Schmidtke A, Lehfeld H, Niklewski G, Hegerl U (2011). Geschlechtsunterschiede in der Saisonalität von Suizidversuchen. Suizidprophylaxe, 38(1), 143-151.
     
  346. Allgaier AK, Liwowsky I, Kramer D, Mergl R, Fejtkova S, Hegerl U (2011). [Screening for depression in nursing homes: Validity of the WHO (Five) Well-Being Index]. Neuropsychiatr, 25(4), 208-215.
     
  347. Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauss M, Baum P, Hegerl U, Schonknecht P (2011). CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Res, 190(2-3), 240-243.
     
  348. van der Feltz-Cornelis CM, Sarchiapone M, Postuvan V, Volker D, Roskar S, Grum AT, Carli V, McDaid D, O\'Connor R, Maxwell M, Ibelshauser A, Van Audenhove C, Scheerder G, Sisask M, Gusmao R, Hegerl U (2011). Best practice elements of multilevel suicide prevention strategies. Crisis, 32(6), 319-333.
     
  349. Schmidt FM, Kratzsch J, Hegerl U, Schönknecht P (2011). Die Rolle der Hypocretine bei affektiven Störungen. Nervenheilkunde, 30(11), 893-897.
     
  350. Schönknecht P, Schindler S, Strauß M, Hegerl U, Geyer S (2011). Morphologie und Dysfunktion hypothalamischer Substrukturen bei affektiven Störungen. Nervenheilkunde, 30(11), 879-883.
     
  351. Strauß M, Sander C, Mergl, Schönknecht P, Hegerl U (2011). Onset-of-Depression-Inventory. Nervenheilkunde, 30(11), 899-901.
     
  352. Mergl R, Schönknecht P, Allgaier AK, Henkel V, Hegerl U (2011). Psychopharmako- und Psycho-therapie bei Patienten mit minorer Depression. Sind die Effekte klinisch bedeutsam? Nervenheilkunde, 30(11), 902-907.
     
  353. Sander C, Schönknecht P (2011). Störungen der Vigilanzregulation bei depressiven Erkrankungen Nervenheilkunde, 30(11), 870-877.
     
  354. Olbrich S, Sander C, Matschinger H, Mergl R, Trenner M, Schönknecht P, Hegerl U (2011). Associations between EEG-vigilance and the autonomous nervous system activity during rest. J Psychophysiol, 25(4), 190-200.
     
  355. Juckel G, Mergl R, Brune M, Villeneuve I, Frodl T, Schmitt G, Zetzsche T, Born C, Hahn K, Reiser M, Moller HJ, Bar KJ, Hegerl U, Meisenzahl EM (2011). Is evaluation of humorous stimuli associated with frontal cortex morphology? A pilot study using facial micro-movement analysis and MRI. Cortex, 47(5), 569-574.
     
  356. Mittermeier V, Leicht G, Karch S, Hegerl U, Moller HJ, Pogarell O, Mulert C (2011). Attention to emotion: auditory-evoked potentials in an emotional choice reaction task and personality traits as assessed by the NEO FFI. Eur Arch Psychiatry Clin Neurosci, 261(2), 111-120.
     
  357. Leicht G, Karch S, Karamatskos E, Giegling I, Moller HJ, Hegerl U, Pogarell O, Rujescu D, Mulert C (2011). Alterations of the early auditory evoked gamma-band response in first-degree relatives of patients with schizophrenia: Hints to a new intermediate phenotype. J Psychiatr Res, 45(5), 699-705.
     
  358. Helmreich I, Wagner S, Mergl R, Allgaier AK, Hautzinger M, Henkel V, Hegerl U, Tadic A (2011). The Inventory of Depressive Symptomatology (IDS-C(28)) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD(17)) in patients with mild major, minor or subsyndromal depression. Eur Arch Psychiatry Clin Neurosci, 261(5), 357-67.
     
  359. Hesse S, Stengler K, Regenthal R, Patt M, Becker GA, Franke A, Knupfer H, Meyer PM, Luthardt J, Jahn I, Lobsien D, Heinke W, Brust P, Hegerl U, Sabri O (2011). The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol, 14(5), 606-617.
     
  360. Pogarell O, Padberg F, Karch S, Segmiller F, Juckel G, Mulert C, Hegerl U, Tatsch K, Koch W (2011). Dopaminergic mechanisms of target detection - P300 event related potential and striatal dopamine. Psychiatry Res, 194(3), 212-218.
     
  361. Drago V, Babiloni C, Bartres-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki HW, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, I (2011). Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage. J Alzheimers Dis, 26(Suppl.3), 159-199.
     
  362. Hegerl U, Hensch T, Mulert C (2011). Neurophysiologische Grundlagen psychischer Erkrankungen. In: Möller HJ, Laux G, Kapfhammer HP, Psychiatrie und Psychotherapie, Band 1: Allgemeine Psychiatrie. (S. 277-292), Heidelberg: Springer.
     
  363. Pogarell O, Hegerl U (2011). Neurophysiologische Untersuchungsmethoden. In: Möller HJ, Laux G, Kapfhammer HP, Psychiatrie und Psychotherapie, Band 1: Allgemeine Psychiatrie. (S. 621-648), Heidelberg: Springer.
     
  364. Hensch T, Strobel A (2011). Differentiellpsychologische Aspekte und ihr Nutzen für die Klinische Psychologie. In: Wittchen HU, Hoyer J, Klinische Psychologie und Psychotherapie. (S. 169-191), Heidelberg: Springer.
     


  365. 2010


  366. Tadic A, Helmreich I, Mergl R, Hautzinger M, Kohnen R, Henkel V, Hegerl U (2010). Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression. J Affect Disord, 120(1-3), 86-93.
     
  367. Hegerl U, Hautzinger M, Mergl R, Kohnen R, Schutze M, Scheunemann W, Allgaier AK, Coyne J, Henkel V (2010). Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm. Int J Neuropsychopharmacol, 13(1), 31-44.
     
  368. Dietrich S, Mergl R, Freudenberg P, Althaus D, Hegerl U (2010). Impact of a campaign on the public's attitudes towards depression. Health Educ Res, 25(1), 135-150 .
     
  369. Hegerl U, Mergl R, Havers I, Schmidtke A, Lehfeld H, Niklewski G, Althaus D (2010). Sustainable effects on suicidality were found for the Nuremberg alliance against depression. Eur Arch Psychiatry Clin Neurosci, 260(5), 401-406.
     
  370. Hegerl U, Himmerich H, Engmann B, Hensch T (2010). Mania and attention-deficit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment? Curr Opin Psychiatry, 23(1), 1-7.
     
  371. Hegerl U, Mergl R (2010). The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences. J Psychopharmacol, 24(4), 445-448.
     
  372. Mergl R, Havers I, Althaus D, Rihmer Z, Schmidtke A, Lehfeld H, Niklewski G, Hegerl U (2010). Seasonality of suicide attempts: association with gender. Eur Arch Psychiatry Clin Neurosci, 260(5), 393-400.
     
  373. Strauss M, Heinritz W, Hegerl U, Kopf A (2010). [Risperidone intoxication in a patient with a genetic predisposition as "poor [non]metabolizer"] Psychiatr Prax, 37(4), 199-201.
     
  374. Varnik P, Sisask M, Varnik A, Laido Z, Meise U, Ibelshauser A, Van Audenhove C, Reynders A, Kocalevent RD, Kopp M, Dosa A, Arensman E, Coffey C, van der Feltz-Cornelis CM, Gusmao R, Hegerl U (2010). Suicide registration in eight European countries: A qualitative analysis of procedures and practices. Forensic Sci Int, 202(1-3), 86-92.
     
  375. Hensch T, Himmerich H, Hegerl U, (2010). Stimulants in bipolar disorder: beyond common beliefs. (to the editor) CNS Spectr, 15(7), 469-470.
     
  376. Sander C, Arns M, Olbrich S, Hegerl U (2010). EEG-vigilance and response to stimulants in paediatric patients with attention deficit/hyperactivity disorder. Clin Neurophysiol, 121(9), 1511-1518.
     
  377. Schoenknecht P, Olbrich S, Sander C, Spindler P, Hegerl U (2010). Treatment of acute mania with modafinil monotherapy. Biol Psychiatry, 67(11), 55-57.
     
  378. Boenisch S, Bramesfeld A, Mergl R, Havers I, Althaus D, Lehfeld H, Niklewski G, Hegerl U (2010). The role of alcohol use disorder and alcohol consumption in suicide attempts--a secondary analysis of 1921 suicide attempts. Eur Psychiatry, 25(7), 414-420.
     
  379. Henkel V, Mergl R, Allgaier AK, Hautzinger M, Kohnen R, Coyne JC, Moller HJ, Hegerl U (2010). Treatment of atypical depression: Post-hoc analysis of a randomized controlled study testing the efficacy of sertraline and cognitive behavioural therapy in mildly depressed outpatients. Eur Psychiatry, 25(8), 491-498.
     
  380. Wilk K, Hegerl U (2010). Time of mood switches in ultra-rapid cycling disorder: a brief review. Psychiatry Res, 180(1), 1-4.
     
  381. Hegerl U, Arensman E, Aromaa E, Coyne J, Gusmao R, Kopp M, Maxwell M, Meise U, Pycha R, Pull C, Reisch T, Scheerder G, Sisask M, Perez Sola V, Tuulari J, van Audenhove C (2010). Improving the care of depressed patients and preventing suicides – the European Alliance Against Depression. German Medical Journal, 11, e74-78.
     
  382. Kocalevent R, Hegerl U (2010). Depression und Suizidalität. Public Health Forum, 18(1), 13e1-13e3.
     
  383. Hegerl U, Kocalevent RD (2010). Nationale und europäische Programme zur Prävention von Suizidalität. Die Psychiatrie, 7(2), 69-73.
     
  384. Hegerl U (2010). S3-Leitlinien "Unipolare Depression": Ist eine aktiv-abwartende Begleitung bei leichten Depressionen vertretbar? Arzneimitteltherapie, 5, 166-169.
     
  385. Hegerl U, Hensch T, Himmerich H (2010). Vigilanzregulationsstörungen als pathogenetischer Faktor bei ADHS und Manie. Neuro aktuell, 4, 33-35.
     
  386. Hegerl U, Heinz I (2010). Depressionsnetzwerke und ihre versorgungspolitische Bedeutung. Ärzteblatt Sachsen, 21(9), 502-505.
     
  387. Hegerl U (2010). S3-Leitlinie "Unipolare Depression": Ist eine aktiv-abwartende Begleitung bei leichten Depressionen vertretbar? Psychopharmakotherapie, 3, 146-148.
     
  388. Hegerl U (2010). Vigilanzregulationsstörungen bei Manie und ADHS. MedReport, 42, 5.
     
  389. Schmidt FM, Brugel M, Kratzsch J, Strauss M, Sander C, Baum P, Thiery J, Hegerl U, Schonknecht P (2010). Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls. Neurosci Lett, 483(1), 20-22.
     
  390. Ertl M, Kirsch V, Leicht G, Karch S, Olbrich S, Reiser M, Hegerl U, Pogarell O, Mulert C (2010). Avoiding the ballistocardiogram (BCG) artifact of EEG data acquired simultaneously with fMRI by pulse-triggered presentation of stimuli. J Neurosci Methods, 186(2), 231-241.
     
  391. Leicht G, Kirsch V, Giegling I, Karch S, Hantschk I, Moller HJ, Pogarell O, Hegerl U, Rujescu D, Mulert C (2010). Reduced Early Auditory Evoked Gamma-Band Response in Patients with Schizophrenia. Biol Psychiatry, 67(3), 224-231.
     
  392. Juckel G, Schumacher C, Giegling I, Assion HJ, Mavrogiorgou P, Pogarell O, Mulert C, Hegerl U, Norra C, Rujescu D (2010). Serotonergic functioning as measured by the loudness dependence of auditory evoked potentials is related to a haplotype in the brain-derived neurotrophic factor (BDNF) gene. J Psychiatr Res, 44(8), 541-546.
     
  393. Mulert C, Leicht G, Hepp P, Kirsch V, Karch S, Pogarell O, Reiser M, Hegerl U, Jager L, Moller HJ, McCarley RW (2010). Single-trial coupling of the gamma-band response and the corresponding BOLD signal. Neuroimage, 49(3), 2238-2247.
     
  394. Mavorgiorgou P, Gohle D, Winter C, Rujescu D, Pogarell O, Mulert C, Bar KJ, Zaudig M, Hegerl U, Juckel G (2010). Low serotonergic function and its normalization by treatment with sertraline in obsessive-compulsive disorder - an auditory evoked potential study. J Clin Psychopharmacol, 30(3), 341-343.
     
  395. Baumann F, Regenthal R, Burgos-Guerrero IL, Hegerl U, Preiss R (2010). Determination of nicotine and cotinine in human serum by means of LC/MS. J Chromatogr B Analyt Technol Biomed Life Sci, 878(1), 107-111.
     
  396. Lewczuk P, Kornhuber J, Vanmechelen E, Peters O, Heuser I, Maier W, Jessen F, Burger K, Hampel H, Frolich L, Henn F, Falkai P, Ruther E, Jahn H, Luckhaus Ch, Perneczky R, Schmidtke K, Schroder J, Kess (2010). Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing. Exp Neurol, 223(2), 366-370.
     
  397. Teipel SJ, Ewers M, Wolf S, Jessen F, Kolsch H, Arlt S, Luckhaus C, Schonknecht P, Schmidtke K, Heuser I, Frolich L, Ende G, Pantel J, Wiltfang J, Rakebrandt F, Peters O, Born C, Kornhuber J, Hampel H (2010). Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease. Psychiatry Res, 182(3), 244-250.
     
  398. Preuss UW, Zetzsche T, Pogarell O, Mulert C, Frodl T, Müller D, Schmidt G, Born C, Reiser M, Möller HJ, Hegerl U, Meisenzahl EM (2010). Anterior cingulum volumetry, auditory P300 in schizophrenia with negative symptoms. Psychiatry Res, 183(2), 133-139.
     
  399. Hübner-Liebermann B, Neuner T, Hegerl U, Klein HE, Hajak G, Spiessl H (2010). Reducing suicides through an Alliance Against Depression. Gen Hosp Psychiatry, 32(5), 514-518.
     
  400. Bermejo I, Kriston L, Schneider F, Gaebel W, Hegerl U, Berger M, Harter M (2010). Sick leave and depression - Determining factors and clinical effect in outpatient care. Psychiatry Res, 180(2-3), 68-73.
     
  401. de Graaf R, Radovanovic M, van Laar M, Fairman B, Degenhardt L, Aguilar-Gaxiola S, Bruffaerts R, de Girolamo G, Fayyad J, Gureje O, Haro JM, Huang Y, Kostychenko S, Lepine JP, Matschinger H, Mora ME, (2010). Early cannabis use and estimated risk of later onset of depression spells: Epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative. Am J Epidemiol, 172(2), 149-159.
     
  402. Cibis A, Hegerl U (2010). Ein Beispiel für Suizidprävention - das Deutsche Bündnis gegen Depression. In: Kirch W, Middeke M, Rychlik R, Aspekte der Prävention. (S. 247-251), Stuttgart: Georg Thieme Verlag.
     
  403. Hegerl U, Niedermeier N (2010). Chancen und Risiken des Internets für psychisch kranke Menschen. In: Burda H, Döpfner M, Hombach B, Rüttgers J, 2020 - Gedanken zur Zukunft des Internets. (S. 61-66), Essen: Klartext Verlag.
     
  404. Arns M, Gunkelman J, Olbrich S, Sander C, Hegerl U (2010). EEG vigilance and phenotypes in neuropsychiatry: implications for intervention. In: Coben R, Evans J, Neurofeedback of neuromudulation technique and applications. (S. 79-115), London: Elsevier.
     
  405. Hegerl U, Kocalevent RD, Schönknecht P (2010). Depression: Verbesserung der Erkennung und Behandlung im höheren Lebensalter. In: Stoppe G, Die Versorgung psychisch kranker alter Menschen. Bestandsaufnahme und Herausforderung für die Versorgungsforschung. (S. 19-24), Köln: Deutscher Ärzte-Verlag.
     


  406. 2009


  407. Blume A, Mergl R, Niedermeier N, Kunz J, Pfeiffer-Gerschel T, Karch S, Havers I, Hegerl U (2009). [Evaluation of an online discussion forum for depressive patients and their relatives - an examination focussing motives and effects of participation.] Neuropsychiatr, 23(1), 42-51.
     
  408. Olbrich S, Mulert C, Karch S, Trenner M, Leicht G, Pogarell O, Hegerl U (2009). EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement. Neuroimage, 45(2), 319-332.
     
  409. Värnik A, Kolves K, Allik J, Arensman E, Aromaa E, , ... , Realo A, Reisch T, Schmidtke A, Pérez Sola V, Wittenburg L, Hegerl U (2009). Gender issues in suicide rates, trends and methods among youths aged 15-24 in 15 European countries. J Affect Disord, 113(1-3), 216-226.
     
  410. Hegerl U, Wittenburg L, Gottlebe K, Arensmann E, van Audenhove C, Bouleau JH, van der Feltz-Cornelis CM, Giupponi G, Gusmao R, Kopp M, Marusic A, Maxwell M, Meise U, Oskarsson H, Pull C, Schmidtke A, (2009). Focus on mental health care reforms in Europe: the European alliance against depression: a multilevel approach to the prevention of suicidal behavior. Psychiatr Serv, 60(5), 596-599.
     
  411. Hegerl U, Schönknecht P (2009). [Subdiagnostic depression. Are there treatments with clinically relevant effects?] Nervenarzt, 80(5), 532-539.
     
  412. Allgaier AK, Kramer D, Mergl R, Hegerl U (2009). [Improvement of knowledge and attitudes towards depression and suicidality in geriatric caregivers: evaluation of an advanced training program] Z Gerontol Geriatr, 42(3), 228-235.
     
  413. Hegerl U, Sander C, Olbrich S, Schönknecht P (2009). Are psychostimulants a treatment option in mania? Pharmacopsychiatry, 42(5), 169-174.
     
  414. Hegerl U, Mergl R, Bottner AC, Holtschmidt-Täschner B, Born C, Seemüller F, Scheunemann W, Henkel V, Angst J (2009). Geschwindigkeit des Depressionsbeginns: Ein Merkmal zur Differenzierung uni- und bipolarer affektiver Störungen. Nervenheilkunde, 28(4), 202-204.
     
  415. Liwowsky I, Kramer D, Mergl R, Bramesfeld A, Allgaier AK, Poppel E, Hegerl U (2009). Screening for depression in the older long-term unemployed. Soc Psychiatry Psychiatr Epidemiol, 44(8), 622-627.
     
  416. Hegerl U (2009). Minore Depression - ein minores Leiden? ÄP NeurologiePsychiatrie, 10, 26-31.
     
  417. Hegerl U, Mergl R (2009). Depressionen - Verhüten psychologische Interventionen den Rückfall? InFo Neurologie & Psychiatrie, 11(4), 26.
     
  418. Hegerl U, Wittenburg L, Arensman E, Van Audenhove C, Coyne JC, McDaid D, van der Feltz-Cornelis CM, Gusmao R, Kopp M, Maxwell M, Meise U, Roskar S, Sarchiapone M, Schmidtke A, Varnik A, Bramesfeld A (2009). Optimizing suicide prevention programs and their implementation in Europe (OSPI Europe): an evidence-based multi-level approach. BMC Public Health, 9, 428.
     
  419. Kramer D, Allgaier AK, Fejtkova S, Mergl R, Hegerl U (2009). Depression in nursing homes: Prevalence, recognition, and treatment. Int J Psychiat Med, 39(4), 345-358.
     
  420. Förstl H, Werheid K, Ulm K, Schönknecht P, Schmidt R, Pantel J, Horr R, Gutzmann H, Gertz HJ, Frölich L, Bickel H (2009). [MCI-plus: mild cognitive impairment with rapid progression] Dtsch Med Wochenschr, 134(3), 88-91.
     
  421. Förstl H, Bickel H, Frölich L, Gertz HJ, Gutzmann H, Hörr R, Pantel J, Schmidt R, Schönknecht P, Ulm K, Werheid K (2009). [MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy] Dtsch Med Wochenschr, 134(1-2), 39-44.
     
  422. Bermejo I, Schneider F, Kriston L, Gaebel W, Hegerl U, Berger M, Härter M (2009). Improving outpatient care of depression by implementing practice guidelines: a controlled clinical trial. Int J Qual Health Care, 21(1), 29-36.
     
  423. Kornhuber J, Schmidtke K, Frolich L, Perneczky R, Wolf S, Hampel H, Jessen F, Heuser I, Peters O, Weih M, Jahn H, Luckhaus C, Hull M, Gertz HJ, Schroder J, Pantel J, Rienhoff O, Seuchter SA, Ruther E, (2009). Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. Dement Geriatr Cogn Disord, 27(5), 404-417.
     
  424. Karch S, Leicht G, Giegling I, Lutz J, Kunz J, Buselmeier M, Hey P, Sporl A, Jager L, Meindl T, Pogarell O, Moller HJ, Hegerl U, Rujescu D, Mulert C (2009). Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task. J Psychiatr Res, 43(15), 1185-1194.
     
  425. Spiessl H, Hübner-Liebermann B, Neunert T, Hegerl U, Klein HE, Hajak G (2009). Senkung der Suizide durch das "Bündnis gegen Depression". Nervenheilkunde, 28(4), 205-210.
     
  426. Amann B, Mergl R, Torrent C, Perugi G, Padberg F, El-Gjamal N, Laakmann G (2009). Abnormal temperament in patients with morbid obesity seeking surgical treatment. J Affect Disord, 118(1-3), 155-160.
     
  427. Amann B, Padberg F, Mergl R, Naber D, Baghai T, Reimers K, El-Giamal N, Erfurth A, Laakmann G (2009). An investigation of temperamental traits in patients with somatoform disorder: do they belong in the affective spectrum? Psychosomatics, 50(6), 605-612.
     
  428. Huang Y, Kotov R, de Girolamo G, Preti A, Angermeyer M, Benjet C, Demyttenaere K, de Graaf R, Gureje O, Karam AN, Lee S, Lepine JP, Matschinger H, Posada-Villa J, Suliman S, Vilagut G, Kessler RC (2009). DSM-IV personality disorders in the WHO World Mental Health Surveys. Br J Psychiatry, 195(1), 46-53.
     
  429. Forstl H, Bickel H, Frolich L, Gertz HJ, Gutzmann H, Horr R, Pantel J, Schmidt R, Schonknecht P, Ulm K, Werheid K (2009). [MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy] Dtsch Med Wochenschr, 134(1-2), 39-44.
     
  430. Schönknecht P, Hegerl U (2009). Elektroenzephalogramm (EEG). In: Mahlberg R, Gutzmann H, Demenzerkrankungen erkennen, behandeln und versorgen. (S. 160-167), Köln: Deutscher Ärzte-Verlag.
     
  431. Hegerl U, Dietrich S, Pfeiffer-Gerschel T, Wittenburg L, Altenhaus D (2009). Education and awareness programmes for adults - selected and multilevel approaches in suicide prevention. In: Wasserman D, Wasserman C, Oxford Handbook of Suicidology. (S. 495-500), Oxford: Oxford University Press.
     
  432. Mulert C, Hegerl U (2009). Integration of EEG and fMRI. In: Kraft E, Gulyás B, Pöppel E, Neural Correlates of Thinking. (S. 95-106), Berlin: Springer.
     
  433. Dietrich S, Wittenburg L, Arensman E, Värnik A, Hegerl U (2009). Suicide and self-harm. In: Gask L, Lester H, Kendrick T, Peveler R, Handbook of Primary Care Mental Health. (S. 125-144), London: RCPsych Publications.
     
  434. Hegerl U (2009). Die Legende vom "Freitod". In: Redaktion Psychologie Heute, Im Labyrinth der Seele. 100 Streifzüge durch die Psychologie. (S. 72-73), Weinheim: Belz Verlag.
     


  435. 2008


  436. Kratzer S, Hegerl U (2008). [Is "Internet Addiction" a Disorder of its Own?] Psychiatr Prax, 35(2), 80-83.
     
  437. Gohle D, Juckel G, Mavrogiorgou P, Pogarell O, Mulert C, Rujescu D, Giegling I, Zaudig M, Hegerl U (2008). Electrophysiological evidence for cortical abnormalities in obsessive-compulsive disorder - a replication study using auditory event-related P300 subcomponents. J Psychiatr Res, 42(4), 297-303.
     
  438. Mulert C, Pogarell O, Hegerl U (2008). Simultaneous EEG-fMRI: perspectives in psychiatry. Clin EEG Neurosci, 39(2), 61-64.
     
  439. Cibis A, Bramesfeld A, Blume A, Havers I, Hegerl U (2008). [Optimised services for depressed patients. The German Alliance Against Depression.] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 51(4), 430-435.
     
  440. Hegerl U, Cibis A, Arensman E, Aromaa E, van Audenhove C, Bouleau J-H, van der Feltz-Cornelis CM, Giupponi G, Gusmäo R, Kopp M, Marusic A, Maxwell M, Meise U, Oskarsson H, Pull C, Ricka R, Schmidke A, (2008). [The „European Alliance Against Depression“ – a four-level intervention programme against depression and suicidality] Suicidologi, 13(1), 12-14.
     
  441. Forstl H, Bickel H, Frölich L, Gertz HJ, Kurz A, Marksteiner J, Monsch AU, Pantel J, Schmidt R, Schönknecht P (2008). [Mild cognitive impairment with predictors of rapid decline] Dtsch Med Wochenschr, 133(9), 431-436.
     
  442. Hegerl U, Bottner AC, Mergl R, Holtschmidt-Taschner B, Seemüller F, Scheunemann W, Schütze M, Grunze H, Henkel V, Angst J, Born C (2008). [Speed of onset of depressive episodes: a clinical criterion helpful for separating uni- from bipolar affective disorders.] Neuropsychiatr, 22(2), 92-99.
     
  443. Värnik A, Kolves K, van der Feltz-Cornelis CM, Marusic A, Oskarsson H, Palmer A, Reisch T, Scheerder G, Arensman E, Aromaa E, Giupponi G, Gusmao R, Maxwell M, Pull C, Szekely A, Sola VP, Hegerl U (2008). Suicide methods in Europe: a gender-specific analysis of countries participating in the "European Alliance Against Depression". J Epidemiol Commun H, 62(6), 545-551.
     
  444. Juckel G, Clotz F, Frodl T, Kawohl W, Hampel H, Pogarell O, Hegerl U (2008). Diagnostic usefulness of cognitive auditory event-related p300 subcomponents in patients with Alzheimers disease? J Clin Neurophysiol, 25(3), 147-152.
     
  445. Hegerl U, Wittmann M, Arensman E, Van Audenhove C, Bouleau JH, Van Der Feltz-Cornelis C, Gusmao R, Kopp M, Löhr C, Maxwell M, Meise U, Mirjanic M, Oskarsson H, Sola VP, Pull C, Pycha R, Ricka R, Tuula (2008). The 'European Alliance Against Depression (EAAD)': a multifaceted, community-based action programme against depression and suicidality. World J Biol Psychiatry, 9(1), 51-58.
     
  446. Hegerl U, Stein M, Mulert C, Mergl R, Olbrich S, Dichgans E, Rujescu D, Pogarell O (2008). EEG-vigilance differences between patients with borderline personality disorder, patients with obsessive-compulsive disorder and healthy controls. Eur Arch Psychiatry Clin Neurosci, 258(3), 137-143.
     
  447. Hegerl U, Bottner AC, Holtschmidt-Täschner B, Born C, Seemüller F, Scheunemann W, Schütze M, Grunze H, Henkel V, Mergl R, Angst J (2008). Onset of depressive episodes is faster in patients with bipolar versus unipolar depressive disorder: evidence from a retrospective comparative study. J Clin Psychiatry, 69(7), 1075-1080.
     
  448. Roick C, Schindler J, Angermeyer MC, Fritz-Wieacker A, Riedel-Heller S, Frühwald S (2008). [Health habits of patients with schizophrenia: a general pattern?] Neuropsychiatr, 22(2), 100-111.
     
  449. Quentin W, König HH, Schmidt JO, Kalk A (2008). Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing. Trop Med Int Health, 13(10), 1245-1256.
     
  450. Schmidt-Recla A, Steinberg H (2008). ["As we're not willing to hang and behead and not able to deport...". On Emil Kraepelin's influence on Franz von Liszt] Nervenarzt, 79(3), 295-304.
     
  451. Schönknecht P, Hegerl U (2008). Der "erschöpfte" Mensch - Depressionen erkennen und behandeln epd Dokumentation, 41, 6-8.
     
  452. Burgos Guerrero IL, Sander C (2008). Mitten auf der Straße eingenickt... MMW Fortschr Med, 150(51-52), 35-37.
     
  453. Hegerl U (2008). Dösig bei der Kletterpartie, hellwach in der Nacht. MMW Fortschr Med, 150(51-52), 30 f.
     
  454. Hegerl U, Olbrich S, Schönknecht P, Sander C (2008). [Manic behavior as an autoregulatory attempt to stabilize vigilance.] Nervenarzt, 79(11), 1283-1290.
     
  455. Hegerl U (2008). [Brief psychotherapeutic interventions in the general practitioners office] MMW Fortschr Med, 150(22), 26.
     
  456. Cibis A, Hegerl U (2008). Das Deutsche Bündnis gegen Depression. Prävention von Suizidalität durch optimierte Versorgung depressiv Erkrankter. Präv Gesundheitsf, 3(3), 187-192.
     
  457. Hegerl U (2008). Pro und Kontra der Behandlung mit Antidepressiva Arzneimitteltherapie, 26(9), 313-314.
     
  458. Juckel G, Mergl R, Prässl A, Mavrogiorgou P, Witthaus H, Möller HJ, Hegerl U (2008). Kinematic analysis of facial behaviour in patients with schizophrenia under emotional stimulation by films with \"Mr. Bean\". Eur Arch Psychiatry Clin Neurosci, 258(3), 186-191.
     
  459. Kawohl W, Hegerl U, Muller-Oerlinghausen B, Juckel G (2008). [Insights in the central serotonergic function in patients with affective disorders.] Neuropsychiatr, 22(1), 23-27.
     
  460. Juckel G, Gudlowski Y, Müller D, Ozgürdal S, Brüne M, Gallinat J, Frodl T, Witthaus H, Uhl I, Wutzler A, Pogarell O, Mulert C, Hegerl U, Meisenzahl EM (2008). Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia--a replication study. Psychiatry Res, 158(1), 79-82.
     
  461. Juckel G, Kawohl W, Giegling I, Mavrogiorgou P, Winter C, Pogarell O, Mulert C, Hegerl U, Rujescu D (2008). Association of catechol-O-methyltransferase variants with loudness dependence of auditory evoked potentials. Hum Psychopharmacol, 23(2), 115-120.
     
  462. Pogarell O, Koch W, Schaaff N, Popperl G, Mulert C, Juckel G, Moller HJ, Hegerl U, Tatsch K (2008). [123I] ADAM brainstem binding correlates with the loudness dependence of auditory evoked potentials. Eur Arch Psychiatry Clin Neurosci, 258(1), 40-47.
     
  463. Mulert C, Seifert C, Leicht G, Kirsch V, Ertl M, Karch S, Moosmann M, Lutz J, Möller HJ, Hegerl U, Pogarell O, Jäger L (2008). Single-trial coupling of EEG and fMRI reveals the involvement of early anterior cingulate cortex activation in effortful decision making. Neuroimage, 42(1), 158-168.
     
  464. Kawohl W, Giegling I, Mavrogiorgou P, Pogarell O, Mulert C, Möller HJ, Hegerl U, Rujescu D, Juckel G (2008). Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of auditory evoked potentials. Int J Neuropsychopharmacol, 11(4), 477-483.
     
  465. Juckel G, Hegerl U, Giegling I, Mavrogiorgou P, Wutzler A, Schuhmacher C, Uhl I, Brüne M, Mulert C, Pogarell O, Rujescu D (2008). Association of 5-HT1B receptor polymorphisms with the loudness dependence of auditory evoked potentials in a community-based sample of healthy volunteers. Am J Med Genet B Neuropsychiatr Genet, 147B(4), 454-458.
     
  466. Karch S, Jäger L, Karamatskos E, Graz C, Stammel A, Flatz W, Lutz J, Holtschmidt-Täschner B, Genius J, Leicht G, Pogarell O, Born C, Moller HJ, Hegerl U, Reiser M, Soyka M, Mulert C (2008). Influence of trait anxiety on inhibitory control in alcohol-dependent patients: simultaneous acquisition of ERPs and BOLD responses. J Psychiatr Res, 42(9), 734-745.
     
  467. Zetzsche T, Preuss UW, Frodl T, Leinsinger G, Born C, Reiser M, Hegerl U, Möller HJ, Meisenzahl EM (2008). White matter alterations in schizophrenic patients with pronounced negative symptomatology and with positive family history for schizophrenia. Eur Arch Psychiatry Clin Neurosci, 258(5), 278-284.
     
  468. Rueckriegel SM, Blankenburg F, Burghardt R, Ehrlich S, Henze G, Mergl R, Hernaiz Driever P (2008). Influence of age and movement complexity on kinematic hand movement parameters in childhood and adolescence. Int J Dev Neurosci, 26(7), 655-663.
     
  469. Von Korff M, Crane PK, Alonso J, Vilagut G, Angermeyer MC, Bruffaerts R, de Girolamo G, Gureje O, de Graaf R, Huang Y, Iwata N, Karam EG, Kovess V, Lara C, Levinson D, Posada-Villa J, Scott KM, Ormel (2008). Modified WHODAS-II provides valid measure of global disability but filter items increased skewness. J Clin Epidemiol, 61(11), 1132-1143.
     
  470. Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, Bruffaerts R, de Girolamo G, Gureje O, Huang Y, Karam A, Kostyuchenko S, Lepine JP, Mora ME, Neumark Y, Ormel JH, Pinto-Meza A, (2008). Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med, 5, 1053-1066.
     
  471. Nock MK, Borges G, Bromet EJ, Alonso J, Angermeyer MC, Beautrais A, Bruffaerts R, Chiu WT, de Girolamo G, Gluzman S, de Graaf R, Gureje O, Haro JM, Huang Y, Karam E, Kessler RC, Lepine JP, Levinson D, (2008). Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Brit J Psychiat, 192(2), 98-105.
     
  472. Blume A, Hegerl U (2008). Internetbasierte Kommunikation im Kompetenznetz "Depression, Suizidalität": Erfahrungen und Chancen. In: Bauer S, Kordy H, E-Mental-Health. Neue Medien in der psychosozialen Versorgung. (S. 61-72), Heidelberg: Springer Medizin Verlag.
     
  473. Hegerl U, Bottner AC, Mergl R, Blume A, Holtschmidt-Täschner B, Seemüller F, Grunze H, Henkel V, Angst J, Born C (2008). Geschwindigkeit des Depressionsbeginns: Ein Merkmal zur Unterscheidung zwischen uni- und bipolaren affektiven Störungen. In: Marneros A, Röttig D, Biogenese und Psychogenese. (S. 187-197), Regensburg: Roderer Verlag.
     
  474. Hendin H, Wang H, Hegerl U, Xiao S, Li X, Phillips M, Huong TT (2008). Suicide Prevention in Asia: Future Directions. In: Hendin H, Phillips MR, Vijayakumar L, Pirkis J, Wang H, Yip P, Wasserman D, Bertolote JM, Fleischman, Suicide and suicide prevention in Asia. (S. 97-108), Geneva: World Health Organization.
     
  475. Hegerl U, Karch S, Mulert C (2008). Neurophysiologische Grundlagen psychiatrischer Erkrankungen. In: Möller HJ, Laux G, Kapfhammer HP, Psychiatrie & Psychotherapie. (S. 209-225), Berlin: Springer.
     
  476. Hegerl U, Pogarell O (2008). Neurophysiologische Untersuchungsmethoden. In: Möller HJ, Laux G, Kapfhammer HP, Psychiatrie & Psychotherapie. (S. 529-551), Berlin: Springer.
     
  477. Hegerl U, Schäfer R, Havers I (2008). Evaluation gemeindebasierter Intervention zur optimierten Depressionsversorgung und Suizidprävention – Ergebnisse aus dem Kompetenznetz Depression, Suizidalität. In: Kurth BM, Monitoring der gesundheitlichen Versorgung in Deutschland. (S. 133-142), Köln: Deutscher Ärzteverlag.
     
  478. Giupponi G, Hegerl U, Pompili M, Pycha R (2008). Prevenzione alla depressione e al suicidio in Alto Adige. In: Tatarelli R, Pompili M, Il suicidio e la sua prevenzione. (S. 183-200), Rom: Giovanni Fioriti Editore.
     
  479. Hegerl U, Niescken S (2008). Depressionen bewältigen. Die Lebensfreude wiederfinden. In: Hegerl U, Niescken S, Depressionen bewältigen. Die Lebensfreude wiederfinden. (S. 1-168), Stuttgart: Trias.
     


  480. 2007


  481. Juckel G, Pogarell O, Augustin H, Mulert C, Müller-Siecheneder F, Frodl T, Mavrogiorgou P, Hegerl U (2007). Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry, 68(8), 1206-1212.
     
  482. Hegerl U (2007). Antidepressants and suicidality : Risk-benefit analysis. Nervenarzt, 78(1), 7-14.
     
  483. Mulert C, Leicht G, Pogarell O, Mergl R, Karch S, Juckel G, Möller HJ, Hegerl U (2007). Auditory cortex and anterior cingulate cortex sources of the early evoked gamma-band response: Relationship to task difficulty and mental effort. Neuropsychologia, 45(10), 2294-2306.
     
  484. Pogarell O, Mulert C, Hegerl U (2007). Event-related potentials in psychiatry. Clin EEG Neurosci, 38(1), 25-34.
     
  485. Mergl R, Pogarell O, Juckel G, Rihl J, Henkel V, Frodl T, Muller-Siecheneder F, Karner M, Tigges P, Schroter A, Hegerl U (2007). Hand-motor dysfunction in depression: characteristics and pharmacological effects. Clin EEG Neurosci, 38(2), 82-88.
     
  486. Roick C, Fritz-Wieacker A, Matschinger H, Heider D, Schindler J, Riedel-Heller S, Angermeyer MC (2007). Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol, 42(4), 268-276.
     
  487. Pogarell O, Juckel G, Norra C, Leicht G, Karch S, Schaaff N, Folkerts M, Ibrahim A, Mulert C, Hegerl U (2007). Prediction of clinical response to antidepressants in patients with depression: neurophysiology in clinical practice. Clin EEG Neurosci, 38(2), 74-77.
     
  488. Mergl R, Seidscheck I, Allgaier AK, Moller HJ, Hegerl U, Henkel V (2007). Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition. Depress Anxiety, 24(3), 185-195.
     
  489. Althaus D, Niklewski G, Schmidtke A, Hegerl U (2007). [Changes in the frequency of suicidal behaviour after a 2-year intervention campaign.] Nervenarzt, 78(3), 272-282.
     
  490. Schlee A, Hegerl U (2007). Das Kompetenznetz Depression, Suizidalität. Psychiatrie und Dialog, 21(1), 10-14.
     
  491. Pfeiffer-Gerschel T, Wittmann M, Hegerl U (2007). [The "European Alliance Against Depression". An European network targeting at effective care in community-based services for persons suffering from depressive disorders] Neuropsychiatrie, 21(1), 51-58.
     
  492. Hegerl U, Pfeiffer-Gerschel T (2007). [Early detection of depressive illnesses] MMW Fortschr Med, 149(13), 27-31.
     
  493. Hegerl U (2007). Rollentausch: Der Arzt als Patient (Editorial) MMW-Fortschr Med, 149(27-28), 26.
     
  494. Hegerl U, Schäfer R (2007). Depressive Störungen in der hausärztlichen Praxis. Besser erkennen und behandeln. Forum Sanitas, 2, 6-8.
     
  495. Schäfer R, Hegerl U (2007). Suizidprävention durch ein gemeindebasiertes Awareness Programm. Das Bündnis gegen Depression in Deutschland und Europa. Psychiatrie, 4(3), 159-165.
     
  496. Steinberg H, Schmidt-Recla A, Schmideler S (2007). Forensic psychiatry in nineteenth-century saxony: the case of woyzeck. Harv Rev Psychiatry, 15(4), 169-180.
     
  497. Hegerl U (2007). [Burnout--alcohol problems--risk of suicide. Role reversal: the doctor as patient] MMW Fortschr Med, 149(27-28), 26-27.
     
  498. Hegerl U, Schäfer R (2007). [From the Nuremberg Alliance Against Depression to a European network (EAAD)--extending community-based awareness-campaigns on national and European level] Psychiatr Prax, 34 Suppl 3, S261-S265.
     
  499. Bramesfeld A, Havers I, Hegerl U (2007). Depressive Erkrankungen: Ausmaß, Versorgung und Herausforderungen an die Versorgungsforschung. Die Ersatzkasse, 87, 352-357.
     
  500. Wilk K, Havers I, Bramesfeld A, Hegerl U (2007). Früherkennung von Depression und Prävention von Suizidalität im Alter Public Health Forum, 15(4), 26-28.
     
  501. Bramesfeld A, Havers I, Hegerl U (2007). Angsterkrankungen und Depressionen in Deutschland: Bestandsaufnahme und Perspektiven. Impu!se, 57, 2-3.
     
  502. Schmidt-Recla A, Steinberg H (2007). Eine publizistische Debatte als Geburtsstunde des "Marburger Programms". Zeitschrift für die gesamte Strafrechtswissenschaft, 119(2), 195-213.
     
  503. Karch S, Graz C, Jager L, Karamatskos E, Flatz AS, Lutz J, Holtschmidt-Taschner B, Genius J, Reiser GL, Moller HJ, Hegerl U, Soyka M, Mulert C (2007). Influence of anxiety on electrophysiological correlates of response inhibition capacities in alcoholism. Clin EEG Neurosci, 38(2), 89-95.
     
  504. Mulert C, Juckel G, Brunnmeier M, Leicht SK, Mergl R, Möller HJ, Hegerl U, Pogarell O (2007). Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication. Clin EEG Neurosci, 38(2), 78-81.
     
  505. Mulert C, Juckel G, Brunnmeier M, Karch S, Leicht G, Mergl R, Moller HJ, Hegerl U, Pogarell O (2007). Prediction of treatment response in major depression: integration of concepts. J Affect Disord, 98(3), 215-225.
     
  506. Juckel G, Hegerl U, Giegling I, Mavrogiorgou P, Gallinat J, Augustin H, Mulert C, Pogarell O, Rujescu D (2007). Loudness dependence of auditory evoked potentials is not associated with polymorphisms or haplotypes in the serotonin transporter gene in a community-based sample of German healthy volunteers. Psychiatry Res, 153, 183-187.
     
  507. Koch W, Schaaff N, Pöpperl G, Mulert C, Juckel G, Reicherzer M, Ehmer-von Geiso C, Möller HJ, Hegerl U, Tatsch K, Pogarell O (2007). [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. J Psychiatry Neurosci, 32(4), 234-240.
     
  508. Ormel J, Von Korff M, Burger H, Scott K, Demyttenaere K, Huang YQ, Posada-Villa J, Pierre Lepine J, Angermeyer MC, Levinson D, de Girolamo G, Kawakami N, Karam E, Medina-Mora ME, Gureje O, Williams D, (2007). Mental disorders among persons with heart disease - results from World Mental Health surveys. Gen Hosp Psychiatry, 29(4), 325-334.
     
  509. Pogarell O, Koch W, Pöpperl G, Tatsch K, Jakob F, Mulert C, Grossheinrich N, Rupprecht R, Möller HJ, Hegerl U, Padberg F (2007). Acute prefrontal rTMS increases striatal dopamine to a similar degree as d-amphetamine. Psychiatry Res, 156, 251-255.
     
  510. Bermejo I, Frey C, Kriston L, Schneider F, Gaebel W, Hegerl U, Berger M, Härter M (2007). Stability of the effects of guideline training in primary care on the identification of depressive disorders. Primary Care Commun, 12(3-4), 99-107.
     
  511. Härter M, Bermejo I, Komarahadi F, Schneider F, Hegerl U, Niebling W, Berger M (2007). Diagnose und Therapie depressiver Erkrankungen. In: Härter M, Praxismanual Depression. Diagnostik und Therapie erfolgreich umsetzen. (S. 7-38), Köln: Deutscher Ärzte-Verlag.
     
  512. Hegerl U, Schäfer R, Pfeiffer-Gerschel T, Ziervogel A, Althaus D (2007). Bündnis gegen Depression. In: Härter M, Praxismanual Depression. Diagnostik und Therapie erfolgreich umsetzen. (S. 39-46), Köln: Deutscher Ärzte-Verlag.
     
  513. Althaus D, Schäfer R, Hegerl U (2007). Train-the-Trainer-Seminare. In: Härter M, Praxismanual Depression. Diagnostik und Therapie erfolgreich umsetzen. (S. 53-60), Köln: Deutscher Ärzte-Verlag.
     
  514. Althaus D, Schäfer R, Hegerl U (2007). Durchführung von Rollenspielen. In: Härter M, Bermejo I, Niebling W, Praxismanual Depression. Diagnostik und Therapie erfolgreich umsetzen. (S. 61-64), Köln: Deutscher Ärzte-Verlag.
     


  515. 2006


  516. Henkel V, Mergl R, Allgaier AK, Kohnen R, Moller HJ, Hegerl U (2006). Treatment of depression with atypical features: a meta-analytic approach. Psychiatry Res, 141(1), 89-101.
     
  517. Schäfer R, Althaus D, Brosius HB, Hegerl U (2006). Media coverage on suicide in Nurembergs daily papers - frequency and form of the reporting before and during media-intervention with guidelines. Psychiatr Prax, 33(3), 132-137.
     
  518. Pfeiffer-Gerschel T, Schlee A, Hegerl U (2006). The German Research Network on depression and suicidality. Med Klin (Munich), 101(6), 505-508.
     
  519. Hegerl U (2006). Can mental disorders be "clicked away"? MMW Fortschr Med, 148(31-32), 21-22.
     
  520. Pfeiffer-Gerschel T, Niedermeier N, Hegerl U (2006). Modern discussion forum "depression, suicidality". MMW Fortschr Med, 148(31-32), 22-27.
     
  521. Hegerl U, Althaus D, Schmidtke A, Niklewski G (2006). The alliance against depression: 2-year evaluation of a community-based intervention to reduce suicidality. Psychol Med, 36, 1225-1233.
     
  522. Niedermeier N, Pfeiffer-Gerschel T, Hegerl U (2006). Von unseren Patienten lernen - Ein Erfahrungsbericht nach fünf Jahren Diskussionsforum im Rahmen des Kompetenznetzes "Depression, Suizidalität". Nervenheilkunde, 25(5), 361-367.
     
  523. Hegerl U (2006). Vom Leben isoliert - Depressionen erkennen und behandeln. Gesundheit im Beruf, 52(1), 4-6.
     
  524. Hegerl U, Besserer K (2006). Depression: eine Krankheit mit vielen Gesichtern. MMW-Fortschr Med, 148(21), 77-80.
     
  525. Pogarell O, Juckel G, Mavrogiorgou P, Mulert C, Folkerts M, Hauke W, Zaudig M, Moller HJ, Hegerl U (2006). Symptom-specific EEG power correlations in patients with obsessive-compulsive disorder. Int J Psychophysiol, 62(1), 87-92.
     
  526. Harter M, Bermejo I, Ollenschlager G, Schneider F, Gaebel W, Hegerl U, Niebling W, Berger M (2006). Improving quality of care for depression: the German Action Programme for the implementation of evidence-based guidelines. Int J Qual Health Care, 18(2), 113-119.
     
  527. Taleb M, Rouillon F, Hegerl U, Hamdani N, Gorwood P (2006). Programmes against depression. Encephale, 32(1-1), 9-15.
     
  528. Mulert C, Juckel G, Giegling I, Pogarell O, Leicht G, Karch S, Mavrogiorgou P, Moller HJ, Hegerl U, Rujescu D (2006). A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials. Neuropsychopharmacology, 31(6), 1335-1344.
     
  529. Pogarell O, Hegerl U, Mulert C (2006). Electroconvulsive therapy and nonconvulsive status epilepticus - response to anticonvulsants might solve the dilemma. Pharmacopsychiatry, 39(3), 120.
     
  530. Sterr A, Padberg F, Amann B, Mergl R, Mulert C, Juckel G, Hegerl U, Pogarell O (2006). Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline. J Clin Psychiatry, 67(2), 325-326.
     
  531. Pogarell O, Koch W, Popperl G, Tatsch K, Jakob F, Zwanzger P, Mulert C, Rupprecht R, Moller HJ, Hegerl U, Padberg F (2006). Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study. J Psychiatr Res, 40(4), 307-314.
     
  532. Hegerl U, Zaudig M (2006). Antidepressiva. In: Zaudig M, Trautmann R, Joraschky P, Möller HJ, Rupprecht R, Saß H, Hegerl U, Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. (S. 65-67), Berlin: Springer.
     
  533. Hegerl U (2006). Antidepressiva, trizyklische. In: Zaudig M, Trautmann R, Joraschky P, Möller HJ, Rupprecht R, Saß H, Hegerl U, Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. (S. 67-69), Berlin: Springer.
     
  534. Hegerl U (2006). Amitriptylin. (u.a. Therapeutika) In: Zaudig M, Trautmann R, Joraschky P, Möller HJ, Rupprecht R, Saß H, Hegerl U, Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. (S. insg. 14 Seiten), Berlin: Springer.
     
  535. Hegerl U (2006). Clomipramin. In: Zaudig M, Trautmann R, Joraschky P, Möller HJ, Rupprecht R, Saß H, Hegerl U, Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. (S. 159-161), Berlin: Springer.
     
  536. Hegerl U (2006). Serotoninsyndrom. In: Zaudig M, Trautmann R, Joraschky P, Möller HJ, Rupprecht R, Saß H, Hegerl U, Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. (S. 710-712), Berlin: Springer.
     
  537. Hegerl U (2006). Serotonin-Wiederaufnahmehemmer. In: Zaudig M, Trautmann R, Joraschky P, Möller HJ, Rupprecht R, Saß H, Hegerl U, Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. (S. 712-714), Berlin: Springer.
     


  538. 2005


  539. Schmidt CK, Angermeyer MC, Riedel-Heller SG (2005). Prevention -- a topic in social-psychiatric research? Psychiatr Prax, 32(7), 358-362.
     
  540. Power M, Quinn K, Schmidt S, WHOQOL-OLD Group (2005). Development of the WHOQOL-Old Module. Qual Life Res, 14, 2197-2214.